<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS201574</article-id><article-id pub-id-type="doi">10.1101/2024.11.28.625833</article-id><article-id pub-id-type="archive">PPR947164</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A genome-scale single cell CRISPRi map of <italic>trans</italic> gene regulation across human pluripotent stem cell lines</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Peets</surname><given-names>Elin Madli</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhou</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Crepaldi</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Usluer</surname><given-names>Sunay</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dunham</surname><given-names>Alistair</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Braunger</surname><given-names>Jana M</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Strauss</surname><given-names>Magdalena E</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Muraro</surname><given-names>Daniele</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cheam</surname><given-names>Kimberly Ai Xian</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bonder</surname><given-names>Marc Jan</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nogales</surname><given-names>Edgar Garriga</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bassett</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Leonard</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fussing</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Burke</surname><given-names>David</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Parts</surname><given-names>Leopold</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">@</xref></contrib><contrib contrib-type="author"><name><surname>Stegle</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="corresp" rid="CR1">@</xref></contrib><contrib contrib-type="author"><name><surname>Velten</surname><given-names>Britta</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A6">6</xref><xref ref-type="corresp" rid="CR1">@</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cy4wa09</institution-id><institution>Wellcome Sanger Institute</institution></institution-wrap>, <addr-line>Wellcome Genome Campus</addr-line>, <city>Hinxton</city>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02catss52</institution-id><institution>European Bioinformatics Institute</institution></institution-wrap>, European Molecular Biology Laboratory, <city>Hinxton</city>, <country country="GB">UK</country></aff><aff id="A3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cdgtt98</institution-id><institution>Deutsches Krebsforschungszentrum</institution></institution-wrap>, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King’s College London</institution></institution-wrap>, <city>London</city>, <country country="GB">UK</country></aff><aff id="A5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03mstc592</institution-id><institution>European Molecular Biology Laboratory</institution></institution-wrap>, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/038t36y30</institution-id><institution>Heidelberg University</institution></institution-wrap>, <city>Heidelberg</city>, <country country="GB">Germany</country></aff><author-notes><corresp id="CR1">
<label>@</label>Corresponding author: <email>leopold.parts@sanger.ac.uk</email> (LP), <email>oliver.stegle@embl.de</email> (OS), <email>britta.velten@cos.uni-heidelberg.de</email> (BV)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>28</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Population-scale resources of genetic, molecular, and cellular information form the basis for understanding human genomes, charting the heritable basis of disease, and tracing the effects of mutations. Pooled perturbation assays applied to cellular models, probing the effect of many perturbations coupled with an scRNA-seq readout (Perturb-seq), are especially potent references for interpreting disease-linked mutations or gene expression changes. However, the utility of existing maps has been limited by the comprehensiveness of perturbations possible, and the relevance of their cell line context. Here, we present the first genome-scale CRISPR interference (CRISPRi) perturbation map with single-cell RNA sequencing readout across many human genetic backgrounds in human pluripotent cells. To do so, we establish large-scale CRISPRi screening in human induced pluripotent stem cells from healthy donors, using over 20,000 guide RNAs to target 7,226 genes across 34 cell lines from 26 genetic backgrounds, and gather expression data from nearly 2 million cells. We comprehensively map <italic>trans</italic> expression changes induced by the target knockdowns, which complement co-expression patterns in unperturbed cells and facilitate the functional annotation of target genes to biological processes and complexes. Consistency of targeting protein complex members point to protein complexes as a nexus for aggregating transcriptional variation, revealing novel interaction partners. We characterise variation in perturbation effects across donors, with expression quantitative trait loci linked to higher genetic modulation of perturbation effects but overall low replication of trans effects due to knockdown of their corresponding cis regulators. This study pioneers population-scale CRISPR perturbations with single cell readouts that will fuel foundation models for the future of effective modulation of cellular disease phenotypes.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Cellular models allow interrogating disease phenotypes and basic processes in controlled experiments. Undifferentiated induced pluripotent stem cells (iPSCs) are an established system for modelling human development and disease<sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref></sup>. These cells are generated by transforming easy-to-acquire cell types, such as human fibroblasts, into an embryonic-like state, where cells have the capacity to differentiate into the three germ layers. Given the cell-type specificity of many diseases and their inherent ability to self-renew and differentiate, iPSCs represent a powerful tool for studying human variation in cell types that are otherwise difficult to obtain. Consequently, many efforts have been made in identifying the effects of common variation on molecular phenotypes in these cells, e.g. expression quantitative trait locus (eQTL) of common, rare and structural variants<sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref></sup>. While this identified thousands of loci altering expression levels of nearby genes in <italic>cis</italic>, the regulatory landscape underlying the downstream consequences on cellular pathways and function are to a large extent still poorly understood. In particular, existing studies on <italic>trans</italic> effects, in particular in human pluripotent cells, are underpowered due to insufficient genomic resources and small effect sizes of genetic variation in the natural population<sup><xref ref-type="bibr" rid="R3">3</xref></sup>.</p><p id="P3">To complement natural genetic variation, CRISPR has recently emerged as a powerful tool for gene editing, silencing or activation in a targeted and cost-efficient manner. By combining pooled CRISPR-based screening with single-cell gene expression as a read-out, we are now able to study molecular consequences of genetic perturbations on candidate genes<sup><xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R8">8</xref></sup>, identify their downstream targets and infer their biological function and relation to disease. Where non-interventional single-cell expression studies can identify co-expressed genes, inducing a genomic perturbation provides directionality on the nature of a regulatory relationship. To date, CRISPR-based screens have mainly been used to elucidate gene function<sup><xref ref-type="bibr" rid="R9">9</xref></sup> and to identify regulatory networks<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup>. However, resources that map perturbation responses at a genome-scale remain scarce and despite their relevance for understanding human disease and development comprehensive screens have not yet been conducted in iPSCs. Further, while it is well-known that genetic background matters both for mutation impact on disease risk<sup><xref ref-type="bibr" rid="R11">11</xref></sup>, as well as its effect in a functional assay<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup>, no efforts have been made to account for different genetic backgrounds in existing studies so far<sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R15">15</xref></sup>.</p><p id="P4">Here, we present results from a genome-scale CRISPRi screen conducted in iPSCs derived from tens of individuals with scRNA-seq readout. By combining two distinct experimental designs, leveraging the number of perturbations in our dataset, as well as a diverse set of genetic backgrounds, we show that this population genomic perturbation approach with single cell phenotyping can be used to recover known regulatory networks, study cell type-specific biology and compare effects of synthetic dosage change and natural genetic variation. This work represents the second genome-scale CRISPRi screen with scRNA-seq readout and is the only study that accounts for the role of genetic background on gene function, establishing a necessary and fundamental building block for conducting population-scale genetic analyses using genome perturbation techniques.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Measuring knockdown effects across multiple donors at scale</title><p id="P5">First, we set out to chart the landscape of genetic perturbation effects in multiple individuals by performing gene knockdowns using CRISPRi coupled with a single-cell RNA-seq readout (<xref ref-type="fig" rid="F1">Figure 1A</xref>, <xref ref-type="sec" rid="S11">Methods</xref>). To do so, we targeted 7,226 genes in 34 high-quality iPS cell lines derived from 26 distinct healthy donors. The targets were selected to cover genes whose knockdown in iPSCs or cancer cell lines<sup><xref ref-type="bibr" rid="R16">16</xref></sup> exhibited growth defects (2,264 genes and 4,594 genes, respectively, of which 1,725 genes exhibited fitness effects in both) or are highly expressed in iPSCs (2,093 additional genes; <xref ref-type="supplementary-material" rid="SD1">Supplementary Table ST1-1</xref>, <xref ref-type="supplementary-material" rid="SD12">Figure S1A</xref>, <xref ref-type="sec" rid="S11">Methods</xref>). The targeting library included three guide RNAs (gRNAs) per gene from the Dolcetto library<sup><xref ref-type="bibr" rid="R17">17</xref></sup>, as well as 40 non-targeting guides. Following quality control, demultiplexing of cell lines from genotypes, and gRNA assignment (<xref ref-type="sec" rid="S11">Methods</xref>) we obtained 219,206 cells assigned to a source cell line and a targeting guide (median of 8 cells per gRNA and 25 cells per gene; <xref ref-type="sec" rid="S11">Methods</xref>, <xref ref-type="supplementary-material" rid="SD12">Figure S1B</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table ST1-2</xref>), as well as 499,998 control cells assigned to a donor, but either no guide or a non-targeting gRNA. We considered target genes with a minimum coverage of 10 cells (6,673/7,226, 92%) for further analysis based on power calculations (<xref ref-type="supplementary-material" rid="SD12">Figure S1C</xref>, <xref ref-type="sec" rid="S11">Methods</xref>), and computed log-fold changes that quantify the average perturbation effects across all cell lines for each target (6,673 targets x 6,471 expressed genes; <xref ref-type="fig" rid="F1">Figure 1D</xref>, <xref ref-type="sec" rid="S11">Methods</xref>).</p><p id="P6">We next quantified the sources of global variation in the gene expression profiles. As expected for a large-scale single cell RNA sequencing study, technical factors, cell quality and cell line were major drivers of expression heterogeneity between cells (<xref ref-type="fig" rid="F1">Figure 1B-C</xref>, <xref ref-type="supplementary-material" rid="SD12">S1D</xref>). Transcriptional changes induced by CRISPRi knockdown were relatively small compared to those global sources of heterogeneity (<xref ref-type="fig" rid="F1">Figure 1C</xref>), suggesting that CRISPRi targeting induces mostly subtle transcriptional changes rather than complete cell state shifts within the considered time period of 3-6 days post-infection (DPI).</p><p id="P7">The quality of CRISPR targeting can be evaluated based on the on-target expression changes, as well as its effect on downstream genes beyond the target gene (“<italic>trans effect</italic>”). The mean expression of a targeted gene was significantly lower (Benjamini-adjusted p-value &lt; 0.1) compared to control cells for 2,900 of the 4,874 (60%) knockdowns targeting an expressed gene (median log-fold change = -0.42 across all significant on-target <italic>trans</italic> effects), confirming an overall efficient target down-regulation in our system. In contrast, only 0.02% of all target-expressed gene combinations showed evidence of downregulation in <italic>trans</italic> beyond the target (8,833 out of 43,176,109 tested target-expressed gene combinations, <xref ref-type="supplementary-material" rid="SD12">Figure S2-1A</xref>). To assess the quality of our measured <italic>trans</italic> effects, we considered a set of well characterised transcription factors with known regulatory relationships<sup><xref ref-type="bibr" rid="R18">18</xref></sup> across diverse cell types, states, and transitions. All of the 17 significant <italic>trans</italic> effects in our data that overlapped these annotations (<xref ref-type="supplementary-material" rid="SD12">Figure S2-1B</xref>) were concordant with the effect direction expected from the function of the transcription factor. Specifically, knockdown of known activators (16 of 17 significant <italic>trans</italic> effects) resulted in reduced expression of the downstream genes, while knockdown of the known repressor <italic>BACH1</italic> caused up-regulation of its downstream target, <italic>HMOX1</italic>. This remarkable concordance (p = 0.02, binomial test), highlights the potential for validating and charting gene regulatory effects from our data.</p></sec><sec id="S4"><title>Global transcriptional changes caused by gene-dosage reduction</title><p id="P8">Signatures of perturbation effects can reflect regulatory mechanisms in three ways: (i) a <italic>trans</italic> effect of a target gene on downstream genes reflects links in a regulatory network (<xref ref-type="fig" rid="F1">Figure 1D</xref>), (ii) correlation of <italic>trans</italic> effects for two target genes indicates similar function of the targets (<xref ref-type="fig" rid="F1">Figure 1E</xref>), and (iii) correlation of gene responses in <italic>trans</italic> indicates common control by shared regulators (<xref ref-type="fig" rid="F1">Figure 1F</xref>). We next elucidated the factors that determine gene expression control in <italic>trans</italic>, shared <italic>trans</italic> effects (co-regulating targets), and shared regulators (co-regulated expressed genes).</p><sec id="S5"><title>Perturbation effects are largest for targets affecting growth and transcription and acting on highly expressed and variable downstream genes</title><p id="P9">Our resource charts the impact of perturbing genes expressed or essential in iPSCs. Their knockdown resulted in a range of transcriptional change, with some targeted genes inducing hundreds of <italic>trans</italic> effects (<xref ref-type="fig" rid="F2">Figure 2A</xref>). About half of the target genes (51%; 3,374/6,674) had at least one significant <italic>trans</italic> effect upon knockdown, with a mean of 2.57 per target gene. The genes with the highest number of significant <italic>trans</italic> effects have roles in a variety of fundamental biological functions including pluripotency maintenance, transcription and splicing. For example, members of the RNA polymerase associated factor (PAF) complex <italic>PAF1</italic>, <italic>CTR9</italic> and <italic>RTF1</italic>, had 962, 847 and 594 significant <italic>trans</italic> effects, while pluripotency maintenance complex members <italic>CNOT1</italic>, <italic>CNOT3</italic> and <italic>myc</italic>-associated factor <italic>MAX</italic> had 473, 281 and 144, respectively. These genes, which have previously been shown play important roles in the maintenance of pluripotency<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20">20</xref></sup>, reflect the requirements for the stability of the core transcriptional circuitry in human iPSCs on the timescale of several days.</p><p id="P10">Next, we asked which properties of the targeted gene predict the number of significant <italic>trans</italic> effects they have. We included different biological features, as well as the number of assigned cells, in a regularized generalized linear model (<xref ref-type="sec" rid="S11">Methods</xref>), identifying essentiality of the target as the most important feature, which is in line with findings in other cell types<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. This link was weaker for growth effects at earlier time-points (three and five days post-infection), as knockdowns with faster-acting growth defects could suffer from survival bias, with their fitness effects setting in before data were collected (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Among additional features, the number of Gene Ontology annotations, in particular being associated with gene expression<sup><xref ref-type="bibr" rid="R22">22</xref></sup>, as well as evolutionary conservation and protein complex membership of the target gene were also associated with a higher number of significant <italic>trans</italic> effects, an observation consistent with the hypothesis that constrained genes are required for diverse important functions<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup>.</p><p id="P11">We then considered genes that responded in <italic>trans</italic> to the knockdown of one or multiple target genes (here-on referred to as regulators). Over half (67%, 4,365/6,471) of the expressed genes had at least one regulator, with an average of 2.6 (<xref ref-type="supplementary-material" rid="SD12">Figure S2-1C</xref>). Controlling for differences in expression level, the number of associated hallmark biological pathways<sup><xref ref-type="bibr" rid="R25">25</xref></sup> and high expression heritability<sup><xref ref-type="bibr" rid="R1">1</xref></sup> were the strongest predictors of having more regulators, while evolutionary conservation was the most informative predictor for having fewer (<xref ref-type="supplementary-material" rid="SD12">Figure S2-1D</xref>). These observations are consistent with previous hypotheses that genes with essential roles are more likely to be conserved across species and robust to perturbation of upstream regulators within one context, while genes with context-dependent expression levels are more responsive to regulation<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R26">26</xref></sup>.</p><p id="P12">Next, we asked how the uncovered <italic>trans</italic> effects induced by CRISPRi knockdown could yield additional insights into the downstream regulatory consequences of natural genetic variants. Compared to identifying 512 significant <italic>trans</italic> effects by testing the expression of 2,044 genes across 26,877 SNPs in a collection of 1,367 iPSC lines<sup><xref ref-type="bibr" rid="R3">3</xref></sup> (total of 230,010,344 tests; 2.2e-04%), our screen identified a total of 1,328 (3.5%) significant <italic>trans</italic> effects for the 5,127 genes with known <italic>cis</italic> eQTLs among the set of target genes. Out of the <italic>trans</italic> eQTLs identified previously, 67 pairs of <italic>cis</italic> and <italic>trans</italic> genes were also quantified in our data. However, we only found shared signal for one <italic>trans-</italic>eQTL, where the expression of <italic>SLC3A2</italic> was reduced upon knockdown of <italic>SLC7A8</italic>. The other <italic>trans</italic> eQTLs mapped in iPSCs did not yield a strong evidence of enrichment of significant expression change due to CRISPRi (<xref ref-type="supplementary-material" rid="SD12">Figure S2-1E</xref>). The discrepancy between these two sets of trans effects could be explained by stronger effect sizes in the <italic>cis</italic> gene in our data (<xref ref-type="supplementary-material" rid="SD12">Figure S2-2F</xref>). Given the matching experimental cell line context, and the more severe expression perturbation in <italic>cis</italic> due to CRISPRi, this lack of replication of signal from a large natural population suggests that complementary assays such as CRISPRi or CRISPR activation can help to verify regulatory insights from existing <italic>trans</italic> eQTL studies and avoid false negative and positive signal.</p></sec><sec id="S6"><title>Similarity of <italic>trans</italic> effects reveals protein complexes as the nexus for integrating gene expression changes</title><p id="P13">Similarity of perturbation effect has proven to be one of the strongest lines of evidence for a functional link between two genes<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>. We therefore computed the correlation of gene expression changes upon knockdown for every pair of target genes across all expressed genes (<xref ref-type="fig" rid="F1">Figure 1E</xref>). A rich tapestry of functional relationships emerged, that well recapitulated broad functional roles of the targets (<xref ref-type="fig" rid="F2">Figure 2C</xref>). In addition to genomic proximity, which has been shown to be a strong predictor of off-target behavior<sup><xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup>, protein complex co-membership was the strongest predictor of similar <italic>trans</italic> effects (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Indeed, knocking down individual members of a diverse set of protein complexes, such as the integrator complex, EIF3 complex and 26S proteasome, as well as complexes that have previously associated with the maintenance of pluripotency and self-renewal such as the eukaryotic gene expression regulator CCR4-NOT complex<sup><xref ref-type="bibr" rid="R31">31</xref></sup> and histone modification complexes NuA4/Tip60-HAT<sup><xref ref-type="bibr" rid="R32">32</xref></sup>, RNA N6-methyladenosine methyltransferase<sup><xref ref-type="bibr" rid="R33">33</xref></sup> and INO80<sup><xref ref-type="bibr" rid="R34">34</xref></sup>, induced similar expression changes (<xref ref-type="supplementary-material" rid="SD12">Figure S2-2A-B</xref>). Further, target pairs that were part of common co-essentiality modules defined by the Cancer Dependency Map<sup><xref ref-type="bibr" rid="R27">27</xref></sup> also had more similar perturbation effects (<xref ref-type="fig" rid="F2">Figure 2C</xref>). While these modules largely overlap with protein complexes, they additionally link complexes involved in similar functions. For example, knocking down members of RNA polymerase pre-initiation complexes TFIID and TFIIH had similar impact as knocking down members of the mediator complex and members of the RNA polymerase core complex itself (<xref ref-type="supplementary-material" rid="SD12">Figure S2-2C</xref>). This demonstrates how large-scale perturbation screening can link genes across hierarchies spanning from regulatory links to complexes and processes.</p><p id="P14">Consequently, we hypothesised that we could gain insight into the functions of poorly characterised genes by comparing their <italic>trans</italic> effects with those of better-studied protein complex members. We therefore aggregated cells with knockdowns from the same protein complex to obtain an average per-complex <italic>trans</italic> effect and computed its correlation to the <italic>trans</italic> effect of each target gene. We then prioritised 24 candidate gene-complex pairs based on correlation strength and shared known function or cellular compartment<sup><xref ref-type="bibr" rid="R35">35</xref></sup>, and predicted pairwise interaction structures between each target and all complex members using AlphaFold2-multimer<sup><xref ref-type="bibr" rid="R36">36</xref></sup> to assess the biophysical plausibility of the interaction (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table ST2-1</xref>). Complementary information from known complex crystal structures and other biological evidence can help determine if interactions are likely to occur.</p><p id="P15">Our candidate interactions form plausible complexes based on pDockQ<sup><xref ref-type="bibr" rid="R38">38</xref></sup> scores significantly more frequently than random protein pairs (p &lt; 10<sup>-15</sup>, Kolmogorow-Smirnow test) or known non-interacting pairs (p = 5 x 10<sup>-13</sup>), while following a similar distribution to known interactions from CORUM (p = 0.97)<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Eight of the 24 prioritized target-complex pairs had at least one plausible predicted interaction based on both pDockQ score and the visual inspection of the structures predicted by AlphaFold2, of which seven had a coherent interaction with the complex. This includes rediscovering the known structure for the interaction between <italic>DDX39B</italic> and <italic>THOC2</italic> in the TREX complex, and finding plausible interfaces in between <italic>SMC3</italic> and <italic>MED16</italic> from the mediator complex<sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup> as well as <italic>DDX41</italic> and the tri-SNP complex<sup><xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R44">44</xref></sup> via the homologous <italic>LSM2</italic>, <italic>LSM5</italic> and <italic>LSM7</italic> proteins<sup><xref ref-type="bibr" rid="R45">45</xref></sup>, cases where there is known to be an interaction but the structure of it is unknown. Beyond recovering known interactions, we identified four novel interactions with predicted plausible structures: <italic>PHB</italic> with the <italic>TOMM40</italic> complex (<xref ref-type="fig" rid="F2">Figure 2E-F</xref>), <italic>RAB10</italic> with the Paf complex (<xref ref-type="supplementary-material" rid="SD12">Figure S-2D-E</xref>) and <italic>ELP3</italic> and <italic>CTU1</italic> with the EIF2B complex (<xref ref-type="supplementary-material" rid="SD12">Figure S-2-2F-G</xref>). These discoveries highlight the richness of functional data produced by genome-scale perturbation screens.</p></sec><sec id="S7"><title>Genes with similar perturbation responses reflect activated cellular pathways and replicate naturally co-expressed gene clusters</title><p id="P16">Similarity between expression changes of two genes in <italic>trans</italic> across different perturbations indicates shared regulation (<xref ref-type="fig" rid="F1">Figure 1F</xref>). To analyse this effect in our data, we computed correlations between perturbation responses to all targeted genes for every pair of expressed genes and observed high values between members of various cellular stress pathways (<xref ref-type="fig" rid="F2">Figure 2G</xref>). For example, downregulation of the master transcriptional regulator <italic>HIF1A</italic> and its binding partner <italic>ARNT</italic> caused down-expression of glycolysis genes <italic>LDHA</italic>, <italic>GAPDH</italic> and <italic>ALDOA</italic>, while knockdown of <italic>HIF1A</italic> degradation gene <italic>VHL</italic> resulted in the up-regulation of these genes, thus recovering the regulative relationship between hypoxia and the glycolysis pathways<sup><xref ref-type="bibr" rid="R46">46</xref>,<xref ref-type="bibr" rid="R47">47</xref></sup> (<xref ref-type="fig" rid="F2">Figure 2H</xref>, <xref ref-type="supplementary-material" rid="SD12">S2-3A</xref>). Similarly, targeting genes in the mevalonate arm of the cholesterol biosynthesis pathway<sup><xref ref-type="bibr" rid="R48">48</xref></sup> resulted in the up-regulation of all other genes in the pathway (<xref ref-type="supplementary-material" rid="SD12">Figure S2-3B-C</xref>) indicating a shared feedback mechanism regulating their expression.</p><p id="P17">We next quantified which annotations best predict similarity of perturbation responses for all gene pairs and found co-expression of single-cell wild-type gene expression<sup><xref ref-type="bibr" rid="R49">49</xref></sup> to be most informative (Pearson’s R = 0.41; <xref ref-type="supplementary-material" rid="SD12">Figure S2-3D-E</xref>, <xref ref-type="fig" rid="F2">Figure 2G</xref>). In addition to cellular stress pathways and common protein complex membership (<xref ref-type="supplementary-material" rid="SD12">Figure S2-3D</xref>), which share signal with single-cell co-expression modules, this signal was driven by co-regulated expression modules, such as that linked to pluripotency maintenance (<xref ref-type="fig" rid="F2">Figure 2I</xref>; <xref ref-type="supplementary-material" rid="SD12">Figure S2-3F</xref>). We observed co-regulation of a set of five commonly used iPSC marker genes, <italic>CD24</italic>, <italic>TERF1</italic>, <italic>TDGF1</italic>, <italic>L1TD1</italic> and <italic>DNMT3B<sup><xref ref-type="bibr" rid="R50">50</xref>–<xref ref-type="bibr" rid="R56">56</xref></sup></italic>, which are also typically co-expressed in wild-type iPSCs<sup><xref ref-type="bibr" rid="R49">49</xref></sup>. The knockdowns that drove the shared signal were master pluripotency regulator <italic>OCT4</italic> and knockdowns with predicted off-target effects (<xref ref-type="supplementary-material" rid="SD4">Supplementary Table ST2-2</xref>, <xref ref-type="sec" rid="S11">Methods</xref>) and components of the mediator and Paf complexes, which resulted in their down-regulation, and NuA4 complex member <italic>ING3</italic> gene, <italic>CNOT1</italic> and the <italic>MAX</italic> transcription factor, which resulted in the up-regulation of these genes, all of which have previously been attributed to the maintenance of stem cell pluripotency and development<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R57">57</xref>,<xref ref-type="bibr" rid="R58">58</xref></sup>. The finding of expression co-variation between individuals in natural populations to mirror common perturbation responses is of practical importance, as it allows designing efficient screening campaigns based on observational data. For example, savings on sequencing costs can be achieved by choosing a small set of genes for targeted capture, informed by correlation patterns in single cell co-expression, reasonably expecting to recover the main perturbation responses thanks to the shared signal.</p></sec></sec><sec id="S8"><title>The influence of genetic background on gene perturbation effects</title><p id="P18">Gene perturbation effects can sometimes be suppressed or exacerbated by genetic background and small molecules<sup><xref ref-type="bibr" rid="R59">59</xref></sup>. We were therefore interested in understanding how often the <italic>trans</italic> regulatory effects that we observe differ in magnitude across healthy individuals, as this would indicate a mechanism for modulation.</p><p id="P19">To understand the malleability of gene perturbation impact by natural genetic variation, we capitalized on the diversity of donors of the induced pluripotent stem cell lines, and asked to what extent the variation of <italic>trans</italic> effects of a gene knockdown across cells could be attributed to genetic factors. We explored a targeted panel of 1,355 guides targeting 444 genes with 20 non-targeting guides, across 20 cell lines from 10 donors (2 lines per donor), focusing on genes more likely to have variable function across different cell lines (<xref ref-type="fig" rid="F3">Figure 3A</xref>, <xref ref-type="sec" rid="S11">Methods</xref>, <xref ref-type="supplementary-material" rid="SD5">Supplementary Table 3-1</xref>). After quality control, we recovered 1,161,864 cells of which we assigned 635,022 (55%) to 444 targets across 19 cell lines, collecting a median of 74 cells per target gene per line (<xref ref-type="supplementary-material" rid="SD12">Figure S3-1A-B</xref>, <xref ref-type="supplementary-material" rid="SD6">Supplementary Table 3-2</xref>). The knockdowns were again effective, with significant down-regulation of over 90% target genes in 15 of the 19 lines (<xref ref-type="supplementary-material" rid="SD12">Figure S3-1C</xref>). For every target gene, we computed <italic>trans</italic> effects on all 6,517 expressed genes (mean log-normalized expression &gt; 0.1) across cell lines and for individual cell lines, following the analysis of the genome-scale screen (<xref ref-type="sec" rid="S11">Methods</xref>). Across lines, the <italic>trans</italic> effects replicated the results from the genome-scale screen (Pearson’s R=0.73 across all <italic>trans</italic> effects that were significant in either screen), confirming that our earlier results were robust and reproducible (<xref ref-type="supplementary-material" rid="SD12">Figure S3-1D</xref>).</p><p id="P20">When comparing perturbation effects in individual cell lines (<xref ref-type="sec" rid="S11">Methods</xref>), we observed patterns consistent between the lines, with similar covariance structure between target genes (<xref ref-type="supplementary-material" rid="SD12">Figure S3-2A-B</xref>) and highly correlated response gene signatures (<xref ref-type="supplementary-material" rid="SD12">Figure S3-2C</xref>). To identify differences between genetic backgrounds, we considered only the 10 cell lines for the 5 donors where both cell lines from the donor indicated high response to CRISPR perturbation (<xref ref-type="supplementary-material" rid="SD12">Figure S3-1C</xref>) and focused on 68,321 <italic>trans</italic> effects (2.4% of all possible ones) that were significant in at least one cell line and could not be attributed to any off-target or cross-mapping effects (line-specific |LFC| &gt; 0.1, Benjamini-Hochberg adjusted p-value &lt; 0.1, <xref ref-type="sec" rid="S11">Methods</xref>). We found 2,941 <italic>trans</italic> effects (4.3% of tested) for which the donor component explained a significant fraction of variance (Benjamini-Hochberg adjusted p-value &lt; 0.1), which we call <italic>heritable effects</italic> (<xref ref-type="sec" rid="S11">Methods</xref>). The knockdowns with the largest excess of heritable <italic>trans</italic> effects included pluripotency maintenance genes such as master pluripotency regulator <italic>OCT4</italic> and <italic>CNOT3</italic>; splicing genes <italic>SNRNP70</italic>, <italic>SRSF1</italic> and <italic>ZMAT2</italic>; as well as <italic>FA2H</italic> and <italic>CACNA1A</italic>, two genes whose misexpression has previously been attributed to the rare diseases hereditary spastic paraplegia and hereditary cerebellar ataxia, respectively<sup><xref ref-type="bibr" rid="R3">3</xref></sup>. Conversely, <italic>trans</italic> effects due to knockdowns of PAF1 complex members <italic>CTR9</italic>, <italic>RTF1</italic> and <italic>CDC73</italic> and EIF3 complex members <italic>EIF3C</italic> and <italic>EIF3B</italic> were heritable less often than expected (<xref ref-type="fig" rid="F3">Figure 3B</xref>, <xref ref-type="supplementary-material" rid="SD12">Figure S3-3A</xref>), indicating lack of segregating variation in the molecular impact of these key structures.</p><p id="P21">The interpretation of a heritable <italic>trans</italic> effect depends on the expression of the downstream gene in the unperturbed state (<xref ref-type="fig" rid="F3">Figure 3C</xref>). If the gene expression was heritable in control cells (consistently variable across donors, Benjamini-Hochberg adjusted p-value &lt; 0.1; 246/2,941 cases), heritable <italic>trans</italic> effects can emerge due to near-complete repression, or other outcomes that remove the variation between donors (“loss in heritability”, 35/246), such as for <italic>C9orf135</italic> expression changes due to <italic>OCT4</italic> knockdown (<xref ref-type="supplementary-material" rid="SD12">Figure S3-3B</xref>). Usually, this was marked by down-regulation of the expressed gene (28 out of 35, 80%, <xref ref-type="fig" rid="F3">Figure 3D</xref>), though there were also several instances where a knockdown increased the expression of a gene in a single donor, removing expression differences between donors. An example for this is the up-regulation of mitochondrial cytochrome b (<italic>MT-CYB</italic>) in kolf_2 and kolf_3 cells upon knocking down various components of the large mitochondrial ribosome such as <italic>MRPL55</italic> (<xref ref-type="supplementary-material" rid="SD12">Figure S3-3C</xref>). Alternatively, expression heritability can be preserved where transcriptional change amplified effects of known genetic regulators like cis eQTLs or was small compared to the natural variation between donors (“maintenance of heritability”, 211/246) (<xref ref-type="supplementary-material" rid="SD12">Figure S3-3D</xref>).</p><p id="P22">In a second scenario, we considered heritability upon knockdown of the target genes to be potentially gained, if we could not find evidence for heritable expression in the control cells (2,695/2,941 cases, p-value &gt; 0.9). Indeed, 251 of these cases showed significant evidence for heritable gene expression after the knockdown, and the majority (187/251; 75%) of them were a result of up-regulation in the expressed gene in a single donor (<xref ref-type="fig" rid="F3">Figure 3E</xref>). Such <italic>trans</italic> effects would often be overlooked when testing across all lines where the dilution of signal results in insignificant <italic>trans</italic> effects for most of these cases (103/187, 55%). This gain in heritability can potentially be explained by genetic differences in the action of responsible genomic regulators, among other mechanistic reasons. We found that 3 of 7 previously mapped <italic>trans</italic> eQTL hotspot genes<sup><xref ref-type="bibr" rid="R3">3</xref></sup> that we knocked down were linked to a heritable <italic>trans</italic> effect showing a gain in heritability in genes not previously linked to the eQTL: <italic>CREB3L2</italic> on <italic>MICU2</italic>, <italic>ZNF208</italic> on <italic>SEH1L</italic> and <italic>ZNF611</italic> on <italic>MOB1A</italic>, (<xref ref-type="fig" rid="F3">Figure 3F</xref>; <xref ref-type="supplementary-material" rid="SD12">S3-3F-G</xref>).</p><p id="P23">Most heritable <italic>trans</italic> effects could not be directly linked to heritable expression before or after knockdown at the chosen significance levels. For example, the expression of <italic>PRKD3</italic> upon <italic>OCT4</italic> knockdown is heritable, and associated to a previously mapped <italic>cis</italic> eQTL at chr2:37614653 (<xref ref-type="fig" rid="F3">Figure 3G</xref>). However, <italic>PRKD3</italic> expression heritability in our wild-type control cells could not be determined (p-value = 0.68) from the small number of donors. Larger screens with more donors will be required to categorize such heritable <italic>trans</italic> effects reliably.</p></sec><sec id="S9"><title>Towards design, implementation, and analysis of genome- and population-scale single cell CRISPR screens</title><p id="P24">The decrease of single cell library preparation and sequencing costs is making perturbation screening across a population, using a rich gene expression readout a reality. We have performed the first genome-scale screen with high-dimensional read-out across multiple individuals, and found that nearly all aspects of experimental design have an impact on the outcomes, which is important to consider in future studies.</p><p id="P25">In the targeted screen, guide identity had the largest effect on the observed <italic>trans</italic> effects among the genetic and experimental factors we tested (<xref ref-type="supplementary-material" rid="SD12">Figure S4A-B</xref>). While effects of different guides for the same target were mostly consistent (median Pearson’s R = 0.61 across all genes with at least 25 <italic>trans</italic> effects), unintended effects have been shown manifest from targeting similar sequences in other regions of the genome<sup><xref ref-type="bibr" rid="R60">60</xref></sup>, in particular where such regions lie in close proximity of a TSS of another gene<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R61">61</xref></sup>. Of 2,067 potential off-target <italic>trans</italic> effects, 112 exhibited significant repression of the predicted off-target gene and, on average, exhibited 24-fold greater variation due to guide than other <italic>trans</italic> effects (p-value = 1.3e-05, two-tailed t-test) (<xref ref-type="sec" rid="S11">Methods</xref>, <xref ref-type="supplementary-material" rid="SD8">Supplementary Table ST4-1</xref>). Even stricter criteria might be needed to rule out all possible off-target effects. Perfect complementarity as short as 9bp of the guide seed sequence and promoter have been observed to result in off-target activity<sup><xref ref-type="bibr" rid="R61">61</xref></sup> and such observations were replicated by those guides fulfilling this criteria on the expression levels of <italic>OCT4</italic> (<xref ref-type="supplementary-material" rid="SD12">Figure S2-3F</xref>).</p><p id="P26">In addition to guide identity, CRISPRi efficacy explained a large portion of variation in the observed <italic>trans</italic> effects (<xref ref-type="supplementary-material" rid="SD12">Figure S4B</xref>). The four lines where expression changes of the targeted genes that were not significant for over 50% of the library saw muted global transcriptional changes (<xref ref-type="supplementary-material" rid="SD12">Figure S3-1C, S3-2C</xref>). Both the CRISPRi on-target efficacy and the gRNA assignment rate were highly predicted by dCas9 expression in the cell line (<xref ref-type="supplementary-material" rid="SD12">Figure S4C</xref>), the latter likely due to the protective effect of the enzyme against degradation. These cell line effects indicate that successful screening requires a high dose of the Cas enzyme, and accounting for its efficacy in analysis, even after experimental selection for highly performing lines.</p><p id="P27">The experimental design required considerations on the number of cells per knockdown, approach to pooling cells from individuals, and timing of the assay were key to ensure that the resulting data were well-powered to draw reliable conclusions. First, depending on the sought effect size, anywhere from 10 to 200 cells may be needed to be profiled, as evaluated from a downsampling experiment (<xref ref-type="supplementary-material" rid="SD12">Figure S1C</xref>). Second, in an additional experiment knocking down 161 genes (<xref ref-type="supplementary-material" rid="SD9">Supplementary Table ST4-2</xref>) in 24 cell lines, and pooling prior to transfection of dCas9-KRAB-MeCP2, we observed that 6 out of 24 lines accounted for 98.4% of all the cells (<xref ref-type="supplementary-material" rid="SD12">Figure S4D</xref>), indicating technical challenge in ensuring balance across cell lines. Finally, in another experiment of 483 guides knocking down 161 genes with strong growth effects (<xref ref-type="supplementary-material" rid="SD9">Supplementary Table ST4-2</xref>) measured 14 days post-infection resulted in only 34% of cells successfully assigned to a guide, and no targets with significant downregulation (<xref ref-type="supplementary-material" rid="SD12">Figure S4E</xref>). In comparison, gRNAs could be successfully assigned for 52% of cells whose knockdown targeted a gene with weak growth effects, and 59% of the targeted genes had significant expression changes (<xref ref-type="supplementary-material" rid="SD12">Figure S4E</xref>). By sequencing earlier on days 3, 4, 5 or 6 post-infection and pooling cell lines late, we were able to recover sufficient numbers of cells in our later experiments (<xref ref-type="supplementary-material" rid="SD12">Figure S1B</xref>) and consistent target down-regulation (<xref ref-type="supplementary-material" rid="SD12">Figure S2-1A</xref>), highlighting the importance of carefully selecting the sequencing time-point when measuring impact of genes with fitness defects.</p></sec></sec><sec id="S10" sec-type="discussion"><title>Discussion</title><p id="P28">We have presented the first study in healthy humans to combine natural genetic variation with engineered perturbations and single cell sequencing readout. The impact of perturbations on gene expression ranges from limited impact to changing expression of thousands of downstream genes and highlights an overall concordance of observations from different research approaches, but also some differences. The main directions of variation in gene expression changes after knockdown are similar to those observed without perturbations in single iPS cells from a larger cohort<sup><xref ref-type="bibr" rid="R49">49</xref></sup> (<xref ref-type="fig" rid="F2">Figure 2G</xref>). Many of these co-expressed gene modules can be explained by a coordinated response to a signal, such as stress factors. When transcription factor perturbations had an effect in our system, they were always consistent with the annotated role of the factor as an activator or repressor. Lead <italic>cis</italic> eQTL SNPs explained substantial variation in heritable downstream perturbation effects as well. However, <italic>trans</italic> eQTLs, perhaps the most direct comparison to our study setup, mostly did not replicate, indicating either false positive mapping results for eQTLs, winner’s curse to diminish their effect sizes, false negative perturbation effects here, or discrepancies in experimental context. Cellular model resources with <italic>trans</italic> regulation maps as we have established here, power the analyses of <italic>cis</italic> eQTLs and expression-altering disease mutations by imputing their <italic>trans</italic> effects <italic>in silico</italic> and prioritising candidate genes.</p><p id="P29">Similar effects of perturbations indicated membership in the same protein complex or co-essentiality module. This allowed us to detect most complex members for several pieces of core cellular machinery. In addition, we could identify likely protein complex interaction partners by combining consistency of perturbation effect with AlphaFold2-enabled prediction that forecasts a confident interaction event. Similar screens in other cellular contexts where different complexes impact on gene expression could be used to identify their interaction partners or regulators.</p><p id="P30">Overall, protein complexes emerge as a nexus for integrating transcriptional changes and modulating downstream effects (<xref ref-type="fig" rid="F4">Figure 4</xref>). Differences in gene expression, arising from factors like transcriptional stochasticity, cell cycle stages, epigenetic states, or genetic background, do not always lead to changes in protein abundance due to buffering mechanisms at the protein level<sup><xref ref-type="bibr" rid="R12">12</xref></sup>. For instance, excess uncomplexed proteins resulting from increased mRNA expression may be degraded due to exposure of otherwise hidden hydrophobic residues. Similarly, when rate-limiting components of protein complexes are degraded, the entire complex cannot form, leading to shared phenotypic impacts. These buffering mechanisms ensure that genetic effects on gene expression do not always manifest as changes at the protein level, thereby stabilizing cellular functions as reflected in the overall high degree of consistency in <italic>trans</italic> effects across cell lines. Together, our results indicate that protein complexes play a key role in mitigating the impact of gene expression variability, thus preserving the integrity of downstream processes.</p><p id="P31">A venerable question in genetics is the extent of impact of modifiers, mutations that do not have large independent effects themselves, but modulate others. This is important both to be able to predict mutation impact, but also to identify the effects that can be modified at all, such that other ways to modulate cells, such as small molecules, could also be used. Many such alleles have been mapped in yeast, other model organisms, and human disease genes<sup><xref ref-type="bibr" rid="R62">62</xref>,<xref ref-type="bibr" rid="R63">63</xref></sup>. Our experimental design across multiple donors allowed us to identify perturbation effects that vary between individuals. Such heritable changes are small on average compared to technical impact of batches or sequencing coverage, as well as relative to biological covariates such as cell cycle state or CRISPR reagent efficacy. <italic>Cis</italic> eQTLs were frequently a likely natural cause for these effects, with the lead genetic variant associated to gene expression also influencing the response to perturbation.</p><p id="P32">The technological advances and cost reductions support scaling of genetic screening with single cell sequencing readouts. We have identified several factors that contribute substantially to the success of such campaigns, including strategy of pooling lines, sequencing time point, efficacy of engineering, reflected both by Cas9 activity, as well as on-target perturbation effect, gRNA recovery, and gRNA off-target effects. For CRISPRi specifically, off-targets are more promiscuous, with sequence matches in the 10nt of the PAM-proximal region sufficient to cause substantial unintended effects<sup><xref ref-type="bibr" rid="R61">61</xref></sup>. Large scale screening campaigns should map the impact of these variables separately before the start, in conditions that precisely match the scale-up phase later, to avoid complications.</p><p id="P33">Our study marks the beginning of genome-wide CRISPR screening with population-scale single cell RNA sequencing readout. This approach can be applied in cell models, organoids, and primary cells, where single screens have already provided new insights into human cell workings. Expanding these screens across many individuals and including more diverse genetic backgrounds will advance our understanding of disease causes and untangle genetic effects. While requiring careful technical optimization, such data are essential to building foundation models of individual-specific perturbation responses to genetic and small molecule changes, and ultimately predict and control cell behaviour.</p></sec><sec id="S11" sec-type="methods"><title>Methods</title><sec id="S12"><title>Experimental design</title><sec id="S13"><title>Gene selection for the genome-scale panel</title><p id="P34">Guides were selected for the genome-scale panel based on wild-type expression levels in iPSCs, as well as those that demonstrated growth effects. Guides were then separated into those with targeting genes with fitness effects (fitness genes), which were measured at 3, 4 and 5 DPI, and those without (non-fitness genes), which were measured at 6 DPI. 40 non-targeting control guides from Dolcetto A were used for both panels.</p><p id="P35">To identify genes with fitness effects, we conducted an essentiality screen using the Dolcetto library<sup><xref ref-type="bibr" rid="R17">17</xref></sup>. We used 57,050 guides targeting 18,899 genes from the Dolcetto A library and 57,011 guides targeting 18,897 genes from the Dolcetto B library to knock down a total of 18,940 genes in <italic>fiaj_1</italic> cells and harvested cells at 3, 4, 5, 9 and 10 days post-infection. At each time-point, fitness effects were quantified by calculating the log<sub>2</sub>-fold change of normalised cell counts compared to that of the read counts in the plasmid library<sup><xref ref-type="bibr" rid="R64">64</xref></sup> and genes were considered to have fitness effects if the median fitness effect at day 10 across all guides was less than -1. The three guides with the lowest log<sub>2</sub> fold change at day 10 post-transfection were then chosen for screening. If fewer than 3 guides were available across both Dolcetto A and B libraries, all available guides were chosen. In total, this part of our library consisted of 6,784 guides targeting 2,264 targeted fitness genes.</p><p id="P36">Additional genes, without a fitness effect iPSCs were selected based on fitness effects in cancer cell lines, as well expression level in iPSCs. Fitness effects in cancer cell lines were assessed based on the CERES scores of all 1,376 lines in the DepMap consortium<sup><xref ref-type="bibr" rid="R16">16</xref></sup>. Gene expression in iPSCs was measured in a pilot screen on <italic>fiaj_1</italic> cells and expression values per cell were normalised by total sum scaling with a scale factor of 100,000 and log-transformation with a pseudo-count of 1<sup><xref ref-type="bibr" rid="R65">65</xref></sup>. Additional targets were considered if they were either highly expressed in iPSCs (normalised expression &gt; 0.1), or had strong fitness effects in cancer cell lines and were expressed in iPSCs (genes with a CERES score &gt; 0.22 or &lt;-0.25 on average across all lines or in at least 100 lines and and a normalised expression &gt; 0.01) or had variable fitness effects (genes with a CERES score standard deviation across lines &gt; 0.15 and a normalised expression &gt; 0.01). In addition, the 50 genes with highest CERES score standard deviation but expression &lt; 0.01 were selected. For each gene, 3 guides were selected from the Dolcetto A library, complementing with guides from the Dolcetto B library if less than three guides were available in Dolcetto A. In total, 4,962 genes and 14,883 guides were selected.</p></sec><sec id="S14"><title>Gene selection for the targeted panel</title><p id="P37">Genes were selected for the targeted panel for measuring genetic background effects based on their effect size observed in the genome-scale screens. Only target genes with at least 20 cells per gene, log-normalized expression greater than 0.1 and minimum correlation of significant <italic>trans</italic> effects across timepoints and guides larger than 0.5 were considered for selection. Of these, all genes with more than 12 significant <italic>trans</italic> effects were selected for the panel (n=110 genes, 106 of which were fitness genes). For comparison, we added 97 genes with 5-12 significant <italic>trans</italic> effects (all of which were fitness genes) and 203 genes with fewer than 5 significant <italic>trans</italic> effects (141 of which were fitness genes). In addition, we considered 7 genes that have been linked to eQTLs with many <italic>trans</italic> effects<sup><xref ref-type="bibr" rid="R3">3</xref></sup>, 38 genes associated with monogenic diseases<sup><xref ref-type="bibr" rid="R3">3</xref></sup>, 17 genes with high variance of CERES scores across lines<sup><xref ref-type="bibr" rid="R16">16</xref></sup>, 15 genes with a high expression heritability<sup><xref ref-type="bibr" rid="R1">1</xref></sup> and <italic>ARID1A</italic>, <italic>EZH2</italic> and <italic>BCOR</italic>. Guides were chosen as in the genome-scale screen apart from 5 outlier guides, for which the target gene log-fold change was higher than the upper bound of a 95% confidence interval in a linear regression of guide-level versus target-level log-fold changes and a suitable replacement guide with a similar growth-effect ten days after transfection could be found in the Dolcetto libraries. This resulted in a total of 1,355 guides targeting 444 genes and 20 non-targeting control guides for the targeted panel.</p></sec></sec><sec id="S15"><title>Experimental protocol</title><sec id="S16"><title>Molecular cloning</title><p id="P38">The libraries were cloned into the lentiviral expression library pKLV2-U6gRNA5(BbsI)-ccdb-PGKpuroBFP-W (Addgene 67974)<sup><xref ref-type="bibr" rid="R66">66</xref></sup>. Briefly, the guide libraries were ordered from Twist Biosciences as 215-mer oligo pool. The pool was composed of several sub-pools to allow for the selective amplification of gRNAs that were amplified with subpool specific primers (<xref ref-type="supplementary-material" rid="SD10">Supplementary Table STM-1</xref>). BBSI-digested amplicons encoding gRNAs were inserted into the BBSI-digested vector by Gibson assembly (NEB Gibson Assembly Master Mix) according to manufacturer’s specifications, and transformed by electroporation (NEB 10-beta Electrocompetent E. coli C3020K). Bacterial cells were cultured overnight in liquid culture and plasmid DNA was extracted. The plasmid libraries were pooled together in equimolar ratios to achieve the desired final libraries.</p><p id="P39">For the construction of the pB-CAGGS-dCas9-KRAB-MeCP2-BSD-mScarlet plasmid, the pB-CAGGS-dCas9-KRAB-MeCP2 (Addgene 110824) vector was digested with NotI (NEB) and EcorV (NEB). The EF1α promoter and blasticidin resistance gene was amplified by PCR using primers #1009 and #1010 (<xref ref-type="supplementary-material" rid="SD10">Supplementary Table STM-1</xref>). The SNV40 polyA signal was amplified by PCR using primers #1013 and #1014 (<xref ref-type="supplementary-material" rid="SD10">Supplementary Table STM-1</xref>). The mScarlet sequence was amplified by PCR from plasmid pmScarlet_C1 (Addgene 85042) using primers #1016 and #1012 (<xref ref-type="supplementary-material" rid="SD10">Supplementary Table STM-1</xref>). All products were purified with Monarch DNA Cleanup Columns (NEB). T2A sequence was ordered as a gBlock from IDT. A Gibson assembly with 4 fragments is incubated at 50°C for 30 minutes and transformed by electroporation.</p></sec><sec id="S17"><title>Cell culture</title><p id="P40">Human iPSCs were cultured on Vitronectin XF (StemCell Technologies, 07180)-coated plates and mTeSR Plus medium (StemCell Technologies). The medium was changed every other day throughout expansion and all experiments. Cell lines were cultured at 37°C, 5% CO<sub>2</sub>.</p></sec><sec id="S18"><title>dCas+ cell line generation and activity validation</title><p id="P41">For the generation of dCas9-KRAB-MeCP2 iPS cell lines, <italic>3 x 10<sup>5</sup></italic> wild type cells were seeded into 12-well plates with ROCKi containing media. For the transfection of one line, 600ng of pB-CAGGS-dCas9-KRAB-MeCP2-BSD-mScarlet, 300 ng of mPBase<sup><xref ref-type="bibr" rid="R67">67</xref></sup> and 100ng of a reporter plasmid encoding for GFP were mixed with 50ul of Opti-Mem in one tube and 50ul of Opti-Mem was mixed with 2 ul of Lipofectamine Stem (Invitrogen) in another tube. After 5 minutes of incubation at room temperature, the contents of the tubes were mixed together and incubated for another 10-30 minutes at room temperature. During incubation, the media in the wells was refreshed and 0.5ml media was added. After incubation, 100ul of the complexes were added to the wells. 24h after transfection, 1ml of media was added to cells. 48h after transfection, blasticidin (TOKU-E) selection was started using a concentration of 2μg/ml. The cells were cultured in selection for 2 weeks.</p><p id="P42">To validate the dCas9-KRAB-MeCP2 activity of the cells, an adopted method of the previously published Cas9 validation system was used<sup><xref ref-type="bibr" rid="R64">64</xref></sup>. Briefly, cells were transfected with a plasmid that encodes for BFP and GFP and either a mock gRNA or a gRNA targeting GFP TSS. <italic>1 x 10<sup>5</sup></italic> cells were seeded into 24-well plates. Cells were transfected with either the mock or silencing construct using Lipofectamine Stem 24h later. BFP and GFP expression were measured three days after transfection at FACS. dCas9-KRAB-MeCP2 activity was calculated based on the median expression of GFP in BFP positive cells. Two replicate measurements were made for all cell lines for both conditions.</p></sec><sec id="S19"><title>Lentivirus production and determination of lentiviral titer</title><p id="P43">Supernatants containing lentiviral particles were produced by transient transfection of 293FT cells using Lipofectamine LTX (Invitrogen). 5.4 μg of a lentiviral vector, 5.4 μg of psPax2 (Addgene 12260), 1.2 μg of pMD2.G (Addgene 12259) and 12 μl of PLUS reagent were added to 3 ml of OPTI-MEM and incubated for 5 min at room temperature. 36 μl of the LTX reagent was then added to this mixture and further incubated for 30 min at room temperature. The transfection complex was added to 80%-confluent 293FT cells in a 10cm dish containing 10 ml of culture medium. After 48 h viral supernatant was harvested and fresh medium was added. After 24h the lentiviral supernatant was collected and mixed with the first supernatant which was then stored at -80°C.</p><p id="P44">For gRNA library lentiviral titration on dCas9-KRAB-MeCP2 expressing iPSCs, iPSCs were harvested by Accutase (Stemcell Technologies) as single cells. iPSCs (3.6x10<sup>5</sup>/well in 6-well plate) were infected with at least five serial dilutions of lentiviral supernatant supplemented with 10μM Rock inhibitor Y-27632 (Stemcell Technologies). Uninfected cells were used as negative control. The transduced cell mixture was cultured in 6-well plates in 2ml/well. 24h post transduction, the medium was refreshed with mTeSR Plus without Rock inhibitor. After three days of cell culture the cells were harvested for FACS analysis and the level of BFP expression was measured. Virus titer was estimated and scaled up accordingly for subsequent screens.</p></sec><sec id="S20"><title>Screening and sequencing</title><p id="P45">Cells were transduced with the lentivirus aiming for an MOI of 0.2. The cells were seeded at a density of <italic>2.0 x 10<sup>5</sup></italic> to <italic>4.5 x 10<sup>5</sup></italic> depending on the day of harvest. Media was refreshed 24h after transduction. Cells were harvested either on day 3, 4, 5 or 6 after transduction. On collection day, cells were harvested with accutase, spun down and resuspended in eBioscience Fixable Viability Dye eFluor 780 (Invitrogen) that was diluted 5000-fold in eBioscience<sup>™</sup> Flow Cytometry Staining Buffer (Invitrogen). Cells were stained for at least 5 minutes and then filtered with Scienceware<sup>®</sup> Flowmi<sup>™</sup> Cell Strainer (SP Belart). Cells were then sorted based on dead/alive-staining, BFP and mScarlet expression on MA900 Multi-Application Cell Sorter (Sony), The BD Influx<sup>™</sup> (BD Biosciences) or MoFlo XDP Cell Sorter (Beckman Coulter). An equal number of cells were sorted for all the lines. 12 lines and 8 lines were pooled together for the genes with and without fitness effects, respectively, and <italic>1.65 x 10<sup>4</sup></italic> cells were loaded in a 10X inlet. Chromium Next GEM Single Cell 5’ Kit v2 (10X Genomics) was used for transcriptome capture, with a modified protocol where we added an extra primer to the GEM generation mix to capture gRNAs<sup><xref ref-type="bibr" rid="R21">21</xref></sup>.</p></sec></sec><sec id="S21"><title>Computational analysis</title><p id="P46">Unless otherwise stated, all analyses were performed in R (version 4.3.1)<sup><xref ref-type="bibr" rid="R68">68</xref></sup> and Seurat (version 5.0.3).</p><sec id="S22"><title>Read alignment using CellRanger</title><p id="P47">Reads were aligned with CellRanger<sup><xref ref-type="bibr" rid="R69">69</xref></sup> (version 6.0.1), processing each inlet separately. Alignment was conducted using default parameters, using genome build GRch38 as a reference, an adding additional sequences for BFP, mScarlet, BSD and dCas9-KRAB-MeCP2 (<xref ref-type="supplementary-material" rid="SD11">Supplementary Table STM-2</xref>). The sgRNAs were aligned to libraries for the fitness genes and other genes, respectively. For one inlet, the minimum threshold for the GEX/Cite-Seq cell barcode overlap was lowered from 0.1 to 0.01.</p></sec><sec id="S23"><title>De-multiplexing of cells based on natural genetic variation</title><p id="P48">Individual cells were assigned to the source cell lines by de-multiplexing using natural sequence variants, as each pool consisted of lines from different individuals. We first used cellSNP 0.1.7<sup><xref ref-type="bibr" rid="R70">70</xref></sup> to call genotypes from the bam files containing the 10x read sequences for all cells passing the CellRanger filters. We used bcftools<sup><xref ref-type="bibr" rid="R71">71</xref></sup> (version 1.10.2) to subset a list of candidate SNPs<sup><xref ref-type="bibr" rid="R72">72</xref></sup> to only lines present in each inlet and filtered for a min. allele frequency threshold of 0.01 and minimum aggregated count of 20. This output was used in Vireo (version 0.2.1)<sup><xref ref-type="bibr" rid="R73">73</xref></sup> to de-multiplex the cells into the number of lines present in each pool using genotype data for each donor provided by the HipSci consortium<sup><xref ref-type="bibr" rid="R1">1</xref></sup>, modified variant coordinates from GRCh37 to the genome build GRch38 using CrossMap<sup><xref ref-type="bibr" rid="R74">74</xref></sup>. In total, 69% and 72% of cells were uniquely assigned to one cell line in the genome-wide and targeted screens, respectively. Doublets and unassigned cells were removed for further analysis.</p></sec><sec id="S24"><title>Quality control and filtering</title><p id="P49">High quality cells were retained based on three criteria: number of RNA UMI counts per cell, number of unique features per cell and percentage of mitochondrial RNA<sup><xref ref-type="bibr" rid="R75">75</xref></sup>. The number RNA UMI counts and unique features per cell were either bimodal or trimodal for each inlet and we removed cells that were in the lowest mode of number of features and UMI counts using inlet-specific thresholds between 1,926 and 39,260 UMIs per cell (average of 14,186 RNA UMIs across inlets), 2,000 features per cell and a percentage of mitochondrial genes above 10%. After filtering, we assigned cell cycle scores for each cell using Seurat’s <italic>CellCycleScoring</italic> function with cell cycle marker genes retrieved as <italic>cc.genes.updated.2010<sup><xref ref-type="bibr" rid="R65">65</xref></sup></italic>.</p></sec><sec id="S25"><title>Guide assignment</title><p id="P50">To establish an optimal guide assignment strategy, known to impact power and discoveries<sup><xref ref-type="bibr" rid="R76">76</xref></sup>, we considered a pilot data-set knocking down <bold>161</bold> genes with weak fitness effects in 24 iPSC lines (<xref ref-type="supplementary-material" rid="SD8">Supplementary Table ST4-1</xref>). We employed five different tools and evaluated the quality of each assignment by considering the number of knockdowns with significant on-target down-regulation and the median number of cells per guide (<xref ref-type="supplementary-material" rid="SD12">Figure SMA-B</xref>). Based on this, we considered the relative UMI abundance of the most abundant guide with respect to the total number of guide UMIs in a cell for guide assignment in all further analyses. Cells were assigned to a guide if the relative frequency of the most abundant guide was in the upper mode across cells within a cutoff window 0.5 and 1 (median threshold across inlets was 0.75, minimum 0.5 and maximum 0.88) and had a minimum of 3 UMIs in the cell. All other cells were considered unassigned. The percent assigned cells varied across inlets and library sizes, ranging from 9% to 78% in the genome-wide experiments and 37% to 69% in the targeted experiments, with an average of 30% and 55% of cells assigned to a single guide, respectively.</p></sec><sec id="S26"><title>Data integration and variance component analysis</title><p id="P51">For all cells passing quality control we normalised the data by total sum scaling with a scale factor of 10,000 and log-transformation with a pseudo-count of 1 and combined these results using Seurat’s <italic>merge</italic> function, keeping all genes with a minimum normalised expression of 0.1 in all inlets, resulting in a total of 6,471 expressed genes in the genome-wide screen and 6,517 expressed genes in the targeted screen. To produce UMAP plots, we extracted highly variable features using <italic>FindVariableFeatures</italic>, performed PCA using <italic>RunPCA</italic> and calculated a UMAP embedding on the top 20 PCs. To quantify the contribution of the different variables on the transcriptome heterogeneity, we used a linear mixed model on the expression of the 2,000 most highly variable genes in a variance component analysis including donor / cell line, batch / inlet, cell cycle phase, sequencing time point and target gene as random effects and percentage of mitochondrial genes and total number of UMIs per cell as fixed effects. To remove technical and batch differences as well as line-specific effects, the corresponding variables were regressed out from the normalised expression data using <italic>ScaleData</italic> with <italic>vars.to.regress</italic> set to the respective variables and the PCA and UMAP were re-calculated on the residuals of the model.</p></sec><sec id="S27"><title>Quantifying perturbation effects</title><p id="P52">To quantify perturbation effects in the genome-wide screen, we defined all unassigned cells as well as cells assigned to a non-targeting guide as control cells. Based on the gene expression measurements of all control cells, we used a linear model to estimate the effects of cell line, inlet, percent of mitochondrial genes, cell cycle scores and total number of UMIs per cell on the gene expression. To assess the effect of a perturbation within an assigned cell, we calculated the expected expression of each gene based on the linear model and compared this to the observed expression, yielding a <italic>perturbation effect profile</italic> for each cell defined as the difference of the expected and observed expression.</p><p id="P53">To assess overall perturbation effects per guide, per target or per target x line pairing, we averaged these effects across all cells assigned to a guide, target or target x line pairing, respectively, with significance evaluated based on a <italic>z</italic>-test using the residuals variance of the control fit. For the genome-wide screen, targets were considered for analysis if they had a minimum of 10 cells assigned to it, individual guides if they had a minimum of 5 cells. This left a total of 14,982 guides and 6,673 targets to be considered, for which <italic>trans</italic> effects on 6,471 genes were calculated, giving a total of 96,948,522 and 43,180,983 <italic>trans</italic> effects across guides and targets, respectively. For the targeted screen, effects for each of the 444 knockdowns were computed across all lines, as well as separately for each of the lines with where there were least 10 assigned cells (total of 8,204 <italic>trans</italic> effects). As in the genome-wide screen, only the transcriptomic changes for the genes whose log-normalized mean expression was greater than 0.1 were computed (6,517 expressed genes). In total, effects were computed across 53,465,468 target, line, expressed gene triplets.</p><p id="P54">For <italic>cis</italic> effects by natural genetic variants, we used the same procedure to estimate <italic>cis</italic> effects size on the known <italic>cis</italic> gene,using all control cells in the model and replacing the cell line covariate with the number of alternate alleles as a proxy for the genotype of each donor. Cis effect sizes for every eQTL were determined as the model coefficient.</p><p id="P55"><italic>Trans</italic> effects were considered significant if the <italic>p</italic>-value after Benjamini-Hochberg correction across all targets, tested genes and lines (if applicable) was below 0.1.</p></sec><sec id="S28"><title>Power estimation based on down-sampling experiments</title><p id="P56">We estimated the variance of the estimated transcriptional change due to knockdown and impact of the number of assigned cells using a bootstrap procedure. For this, we considered 118 targets of varying effect sizes (11 &lt; # of differentially expressed genes &lt; 551) where the full data set had at least 1,000 assigned cells. For each target, we subsampled all cells with replacement to obtain a simulated dataset of 5, 10, 25, 50, 100, 250, 500 and 1000 cells. Transcriptomic changes for all expressed genes were then computed separately on each of these data sets exactly as on the full data set (see <xref ref-type="sec" rid="S27">Quantifying perturbation effects</xref>) This was done 25 times per knockdown, resulting in a total of 25 separate estimates of transcriptional effect for 8 different sample sizes for each of the 118 targets.</p></sec><sec id="S29"><title>Identifying co-regulated and co-regulating genes</title><p id="P57">To quantify the similarity of targets (and expressed genes) based on their perturbation effects (perturbation response) we calculated Pearson’s correlation between targets (expressed genes) based on the log-fold changes for all 6,471 expressed genes (6,673 well-powered targets). A total of 22,261,128 target-target and 20,933,685 expressed gene-expressed gene pairs were considered for analysis. Two targets (expressed genes) were considered to be co-regulating (co-regulated) if the absolute Pearson’s correlation between their <italic>trans</italic> perturbation (response) was greater than 0.2.</p></sec><sec id="S30"><title>Quantifying heritability of perturbation effects across donors</title><p id="P58">Heritability was estimated in the targeted screen, considering the 5 donors where both cell lines from each donor demonstrated strong response CRISPR perturbation. We considered every target-expressed gene pair where we observed a significant <italic>trans</italic> effect in at least one line (68,321 target x expressed gene pairs). For each of these pairs, the <italic>perturbation effect profile</italic> for every assigned cell obtained from <xref ref-type="sec" rid="S27">Quantifying Perturbation Effects</xref> was fitted with a linear mixed model using normalized target gene expression as a fixed effect and guide, cell line and donor as random effects. Donor effect was quantified by computing the likelihood ratio between the full model and the model without donor as a random effect. To assess significance we created a permutation scheme to obtain an empirical null distribution of the donor effects. For this, donor labels were permuted across cell lines such that two cell lines from one donor were assigned to different donors after the permutation. Thereby we retain the cell line structure in the data but permute the donor structure. This yielded a total of 544 permutations for the 5 pairs of cell lines. Permutations for every target-gene pair were computed until 10 null values greater than or equal to the true value were observed (<italic>stronger observations</italic>), or until 10<sup>4</sup> null values were computed. The empirical p-value was estimated to be <italic>p<sub>td</sub></italic> = <italic>(</italic>max(10, # Stronger Observations + <italic>1)/(</italic>min(# of permutations, 10<sup>4</sup>) <italic>+ 1)</italic>. Effects where the Benjamini-Hochberg adjusted p-value &lt; 0.1 were considered to be significant.</p><p id="P59">All models were fitted using the lmer function from the R package lme4 (v1.1-35.1)<sup><xref ref-type="bibr" rid="R77">77</xref></sup>. Log-likelihood was computed using the logLik function from the R stats package.</p></sec><sec id="S31"><title>Identification of off-target effects</title><p id="P60">A knockdown was considered an off-target effect based on two criteria: <list list-type="simple" id="L1"><list-item><label>-</label><p id="P61"><bold>Genomic proximity</bold>: guide sequence could be mapped to within 1kbp of a transcription start site of another gene in the Fantom 5 database<sup><xref ref-type="bibr" rid="R78">78</xref>,<xref ref-type="bibr" rid="R79">79</xref></sup></p></list-item><list-item><label>-</label><p id="P62"><bold>Sequence similarity</bold>: any sequence with fewer than 3nt mismatches could be mapped to within 1kbp of a transcription start site of another gene in the Fantom 5 database<sup><xref ref-type="bibr" rid="R78">78</xref>,<xref ref-type="bibr" rid="R79">79</xref></sup>.</p></list-item></list></p><p id="P63">To identify guides with potential off-target effects on <italic>OCT4</italic>, we additionally considered any guide in our library whose first 9nt of their seed sequence could be mapped to a region within 2kbp of a transcription start site of <italic>OCT4</italic> in the Fantom 5 database.</p></sec><sec id="S32"><title>Functional annotations</title><p id="P64">Functional annotations were used throughout analysis, such as for predicting number of <italic>trans</italic> effects and number of regulating target genes, similarity of transcriptional effects upon target downregulation and co-perturbation. To do this, we made use of the following annotations:</p><sec id="S33"><title>Conservation scores</title><p id="P65">Conservation scores were obtained for each target from the Bioconductor package phastCons100way.UCSC.hg38 (version 3.7.1)<sup><xref ref-type="bibr" rid="R23">23</xref></sup>.</p></sec><sec id="S34"><title>Wildtype expression, correlation and variance of expression</title><p id="P66">Wild-type gene expression, variance and co-expression was calculated based on undifferentiated iPSCs<sup><xref ref-type="bibr" rid="R49">49</xref></sup>. Values were computed based on the log-normalised expression values after regressing out effects due to donor and technical covariates (percent of mitochondrial genes, total number of UMIs per cell and number of genes expressed). Two genes were considered <italic>co-expressed on the single-cell level</italic> if their absolute Pearson correlation was above 0.3.</p></sec><sec id="S35"><title>Essentiality</title><p id="P67">Essentiality was quantified as described in <italic>Gene selection for the genome-scale panel</italic> based on an iPSC cell line and the DepMap consortium<sup><xref ref-type="bibr" rid="R16">16</xref></sup>.</p></sec><sec id="S36"><title>Expression heritability</title><p id="P68">Heritability of wild-type expression of iPSCs was obtained from the HipSci consortium<sup><xref ref-type="bibr" rid="R1">1</xref></sup>.</p></sec><sec id="S37"><title>Protein-protein interactions</title><p id="P69">Known gene interactions were obtained from the OmniPath database<sup><xref ref-type="bibr" rid="R80">80</xref></sup> using the <italic>import_all_interactions</italic> function from OmnipathR (version 3.10.1)<sup><xref ref-type="bibr" rid="R81">81</xref></sup>. A pair of genes was considered to be interacting if they formed an interaction pair in the OmniPath database (undirected).</p></sec><sec id="S38"><title>Protein complexes</title><p id="P70">Known protein complexes were obtained from the Omnipath database<sup><xref ref-type="bibr" rid="R80">80</xref></sup> using the <italic>import_omnipath_complexes(resources = c(‘CORUM’, ‘hu.MAP’))</italic> function from OmnipathR (version 3.10.1)<sup><xref ref-type="bibr" rid="R81">81</xref></sup>. Pairs of genes were considered to be a protein complex pair if they were both members of at least one common protein complex.</p></sec><sec id="S39"><title>Transcription factor regulation</title><p id="P71">Transcription factor-target gene interactions were obtained from the DoRothEA database<sup><xref ref-type="bibr" rid="R82">82</xref></sup> using the function <italic>get_dorothea</italic> in the decoupleR package (version 2.8.0)<sup><xref ref-type="bibr" rid="R83">83</xref></sup>, using all pairs with confidence level A or B.</p></sec><sec id="S40"><title>Hallmark gene sets</title><p id="P72">Knockdown and target genes were annotated by their membership in release 7.5.1 of the mSigDB hallmark gene sets<sup><xref ref-type="bibr" rid="R25">25</xref></sup>. Two genes were considered to be a hallmark gene set pair if they were both members of at least one gene set.</p></sec><sec id="S41"><title>Co-essentiality</title><p id="P73">Co-essentiality modules were taken from Wainberg et. al.<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. Two genes were considered to be a co-essentiality module pair if they were both members of at least one co-essentiality module.</p></sec><sec id="S42"><title>GO Terms</title><p id="P74">GO term annotations were obtained from the authors of the gProfiler database<sup><xref ref-type="bibr" rid="R84">84</xref></sup>. Pairs of genes were considered to be an enriched gProfiler pair if they had at least 1 GO annotation in common.</p></sec><sec id="S43"><title>Expression Quantitative Loci in Human iPSCs</title><p id="P75">Putative <italic>trans-</italic>eQTLs were obtained from<sup><xref ref-type="bibr" rid="R3">3</xref></sup> on February 27, 2023. A pair was considered a <italic>cis</italic> eQTL<italic>-trans</italic> eQTL pair if the target gene and identified <italic>trans</italic> gene in our data corresponded to a <italic>cis</italic> eQTL gene and its <italic>trans</italic> effect.</p><p id="P76">Unless otherwise stated, prediction was done by fitting an elastic net regression model with <italic>alpha = 0.1</italic> using of the <italic>glmnet</italic> package (version 4.1-8)<sup><xref ref-type="bibr" rid="R85">85</xref></sup>. When predicting the discrete, positive values (i.e. the number of <italic>trans</italic> effects and regulating knockdowns), a Poisson regression was used. When predicting binary response (i.e. similarity of perturbation response or perturbation profiles), a logistic regression was used. To account for differences in statistical power we controlled for the number of cells by adding this as a term in the model.</p></sec></sec><sec id="S44"><title>Protein Complex Prediction</title><p id="P77">We identified candidate complex interactions based on the correlation between candidate target genes downstream effects and those of known complex members (Pearson’s R &gt; 0.2). Candidates were then categorised into known and novel interactions based on literature review and prioritised according to shared function and cellular compartment with the complex. AlphaFold-Multimer<sup><xref ref-type="bibr" rid="R86">86</xref></sup> (version 2.3) was used to model pairwise interactions between each target gene and all members of the candidate complex. pDockQ<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R87">87</xref></sup> scores were calculated for each interaction as well as a random background sample of protein pairs and a set of known protein interactions. We identified plausible target-complex interactions with a combination of manual examination of predicted structures and pDockQ scores. We then aligned the top predicted pairwise target-complex member interactions with known complex structures using PyMol<sup><xref ref-type="bibr" rid="R88">88</xref></sup> (version 2.5 Open-Source).</p></sec><sec id="S45"><title>MOFA</title><p id="P78">Multi-modal factor analysis was used to compare <italic>trans</italic> effects across cell lines using MOFA2 (version 1.12.1)<sup><xref ref-type="bibr" rid="R89">89</xref>,<xref ref-type="bibr" rid="R90">90</xref></sup>. For this, log-fold change values for 445 target genes, expression of 6,517 genes, dCas9-KRAB-MeCP2, BSD and mScarlet and 19 cell lines were z-transformed and input to MOFA with default parameters, with each cell line as a separate view in the model and the number of factors set to 8.</p></sec></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental Table 1-1</label><media xlink:href="EMS201574-supplement-Supplemental_Table_1_1.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplemental Table 1-2</label><media xlink:href="EMS201574-supplement-Supplemental_Table_1_2.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplemental Table 2-1</label><media xlink:href="EMS201574-supplement-Supplemental_Table_2_1.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Supplemental Table 2-2</label><media xlink:href="EMS201574-supplement-Supplemental_Table_2_2.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplemental Table 3-1</label><media xlink:href="EMS201574-supplement-Supplemental_Table_3_1.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEfB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><label>Supplemental Table 3-2</label><media xlink:href="EMS201574-supplement-Supplemental_Table_3_2.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEgB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><label>Supplemental Table 3-3</label><media xlink:href="EMS201574-supplement-Supplemental_Table_3_3.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEhB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD8"><label>Supplemental Table 4-1</label><media xlink:href="EMS201574-supplement-Supplemental_Table_4_1.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEiB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD9"><label>Supplemental Table 4-2</label><media xlink:href="EMS201574-supplement-Supplemental_Table_4_2.tsv" mimetype="text" mime-subtype="tab-separated-values; charset=utf-8" id="d5aAcEjB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD10"><label>Supplemental Table M-1</label><media xlink:href="EMS201574-supplement-Supplemental_Table_M_1.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="d5aAcEkB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD11"><label>Supplemental Table M-2</label><media xlink:href="EMS201574-supplement-Supplemental_Table_M_2.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="d5aAcElB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD12"><label>Supplementary Figures</label><media xlink:href="EMS201574-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d5aAcEmB" position="anchor"/></supplementary-material></sec></body><back><ack id="S46"><title>Acknowledgements</title><p><bold>Grant support</bold>. C.F., E.M.P, Y.Z., K.C., L.C., S.U., A.D., J.S., M.E.S., D.M., E.G.N., A.B., S.L., Y.G., L.P., O.S., B.V. were supported by Wellcome (220540/Z/20/A). M.E.S was supported by Wellcome (220442/Z/20/Z). B.V., J.M.B were supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 540147573.</p></ack><sec id="S47" sec-type="data-availability"><title>Data and code availability</title><list list-type="simple" id="L2"><list-item><label>-</label><p id="P79">Raw data for the genome-scale and targeted screen are available from SRA under the accession number ERP165335.</p></list-item><list-item><label>-</label><p id="P80">Processed data, identified <italic>trans</italic> effects and heritability scores as well as additional data summaries to reproduce the findings from this manuscript are available from Figshare: <ext-link ext-link-type="uri" xlink:href="https://figshare.com/s/14edeeab56eb8a885df3">https://figshare.com/s/14edeeab56eb8a885df3</ext-link></p></list-item><list-item><label>-</label><p id="P81">Code used for processing and analysis of the data is available from GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/claudiafeng123/crispri_scrnaseq_hipsci">https://github.com/claudiafeng123/crispri_scrnaseq_hipsci</ext-link>.</p></list-item><list-item><label>-</label><p id="P82">An App for interactive exploration of the data is available here: <ext-link ext-link-type="uri" xlink:href="https://www.sanger.ac.uk/tool/crispri-scrna-seq-hipsci/">https://www.sanger.ac.uk/tool/crispri-scrna-seq-hipsci/</ext-link></p></list-item></list></sec><fn-group><fn id="FN1" fn-type="con"><p id="P83">Author contributions.</p><p id="P84">Designed project: L.P., C.F., B.V., L.C., Y.Z., E.M.P., S.U.</p><p id="P85">Performed experiments: E.M.P., Y.Z., K.A.X.C., S.C., A.B.</p><p id="P86">Analysed and interpreted data: C.F., B.V., A.D., M.J.B, J.M.B., J.S., M.E.S., D.M., E.G.N., S.L., Y.G., B.F., D.B.</p><p id="P87">Supervised study: L.P., O.S., B.V.</p><p id="P88">Wrote paper: C.F., B.V., L.P., O.S., A.D.</p></fn><fn id="FN2" fn-type="conflict"><p id="P89">Declaration of interests</p><p id="P90">O.S. is a paid advisor of Insitro. Inc. A.B. has been a founder and consultant for EnsoCell since August 2023. L.P. receives remuneration and stock options from ExpressionEdits. The other authors have no other interests to declare.</p></fn><fn id="FN3"><p id="P91"><bold>Resource availability</bold></p><p id="P92"><bold>Lead contact</bold></p><p id="P93">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Leopold Parts (<email>leopold.parts@sanger.ac.uk</email>).</p></fn><fn id="FN4"><p id="P94"><bold>Materials availability</bold></p><p id="P95">This study did not generate new unique reagents.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpinen</surname><given-names>H</given-names></name><name><surname>Goncalves</surname><given-names>A</given-names></name><name><surname>Leha</surname><given-names>A</given-names></name><name><surname>Afzal</surname><given-names>V</given-names></name><name><surname>Alasoo</surname><given-names>K</given-names></name><name><surname>Ashford</surname><given-names>S</given-names></name><name><surname>Bala</surname><given-names>S</given-names></name><name><surname>Bensaddek</surname><given-names>D</given-names></name><name><surname>Casale</surname><given-names>FP</given-names></name><name><surname>Culley</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Common genetic variation drives molecular heterogeneity in human iPSCs</article-title><source>Nature</source><year>2017</year><volume>546</volume><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="pmcid">PMC5524171</pub-id><pub-id pub-id-type="pmid">28489815</pub-id><pub-id pub-id-type="doi">10.1038/nature22403</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubosky</surname><given-names>D</given-names></name><name><surname>D’Antonio</surname><given-names>M</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Smail</surname><given-names>C</given-names></name><name><surname>Donovan</surname><given-names>MKR</given-names></name><name><surname>Young Greenwald</surname><given-names>WW</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>D’Antonio-Chronowska</surname><given-names>A</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Smith</surname><given-names>EN</given-names></name><etal/></person-group><article-title>Properties of structural variants and short tandem repeats associated with gene expression and complex traits</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC7286898</pub-id><pub-id pub-id-type="pmid">32522982</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-16482-4</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Smail</surname><given-names>C</given-names></name><name><surname>Gloudemans</surname><given-names>MJ</given-names></name><name><surname>Frésard</surname><given-names>L</given-names></name><name><surname>Jakubosky</surname><given-names>D</given-names></name><name><surname>D’Antonio</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Ferraro</surname><given-names>NM</given-names></name><name><surname>Carcamo-Orive</surname><given-names>I</given-names></name><name><surname>Mirauta</surname><given-names>B</given-names></name><etal/></person-group><article-title>Identification of rare and common regulatory variants in pluripotent cells using population-scale transcriptomics</article-title><source>Nat Genet</source><year>2021</year><volume>53</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="pmcid">PMC7944648</pub-id><pub-id pub-id-type="pmid">33664507</pub-id><pub-id pub-id-type="doi">10.1038/s41588-021-00800-7</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>A</given-names></name><name><surname>Parnas</surname><given-names>O</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fulco</surname><given-names>CP</given-names></name><name><surname>Jerby-Arnon</surname><given-names>L</given-names></name><name><surname>Marjanovic</surname><given-names>ND</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Burks</surname><given-names>T</given-names></name><name><surname>Raychowdhury</surname><given-names>R</given-names></name><etal/></person-group><article-title>Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>1853</fpage><lpage>1866</lpage><elocation-id>e17</elocation-id><pub-id pub-id-type="pmcid">PMC5181115</pub-id><pub-id pub-id-type="pmid">27984732</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.038</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamson</surname><given-names>B</given-names></name><name><surname>Norman</surname><given-names>TM</given-names></name><name><surname>Jost</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>MY</given-names></name><name><surname>Nuñez</surname><given-names>JK</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Villalta</surname><given-names>JE</given-names></name><name><surname>Gilbert</surname><given-names>LA</given-names></name><name><surname>Horlbeck</surname><given-names>MA</given-names></name><name><surname>Hein</surname><given-names>MY</given-names></name><etal/></person-group><article-title>A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>1867</fpage><lpage>1882</lpage><elocation-id>e21</elocation-id><pub-id pub-id-type="pmcid">PMC5315571</pub-id><pub-id pub-id-type="pmid">27984733</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.048</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datlinger</surname><given-names>P</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Schmidl</surname><given-names>C</given-names></name><name><surname>Krausgruber</surname><given-names>T</given-names></name><name><surname>Traxler</surname><given-names>P</given-names></name><name><surname>Klughammer</surname><given-names>J</given-names></name><name><surname>Schuster</surname><given-names>LC</given-names></name><name><surname>Kuchler</surname><given-names>A</given-names></name><name><surname>Alpar</surname><given-names>D</given-names></name><name><surname>Bock</surname><given-names>C</given-names></name></person-group><article-title>Pooled CRISPR screening with single-cell transcriptome readout</article-title><source>Nat Methods</source><year>2017</year><volume>14</volume><fpage>297</fpage><lpage>301</lpage><pub-id pub-id-type="pmcid">PMC5334791</pub-id><pub-id pub-id-type="pmid">28099430</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.4177</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Hon</surname><given-names>GC</given-names></name></person-group><article-title>Multiplexed Engineering and Analysis of Combinatorial Enhancer Activity in Single Cells</article-title><source>Mol Cell</source><year>2017</year><volume>66</volume><fpage>285</fpage><lpage>299</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="pmid">28416141</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Yofe</surname><given-names>I</given-names></name><name><surname>Lara-Astiaso</surname><given-names>D</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Salame</surname><given-names>TM</given-names></name><name><surname>Tanay</surname><given-names>A</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><article-title>Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>1883</fpage><lpage>1896</lpage><elocation-id>e15</elocation-id><pub-id pub-id-type="pmid">27984734</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Replogle</surname><given-names>JM</given-names></name><name><surname>Saunders</surname><given-names>RA</given-names></name><name><surname>Pogson</surname><given-names>AN</given-names></name><name><surname>Hussmann</surname><given-names>JA</given-names></name><name><surname>Lenail</surname><given-names>A</given-names></name><name><surname>Guna</surname><given-names>A</given-names></name><name><surname>Mascibroda</surname><given-names>L</given-names></name><name><surname>Wagner</surname><given-names>EJ</given-names></name><name><surname>Adelman</surname><given-names>K</given-names></name><name><surname>Lithwick-Yanai</surname><given-names>G</given-names></name><etal/></person-group><article-title>Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq</article-title><source>Cell</source><year>2022</year><volume>185</volume><fpage>2559</fpage><lpage>2575</lpage><elocation-id>e28</elocation-id><pub-id pub-id-type="pmcid">PMC9380471</pub-id><pub-id pub-id-type="pmid">35688146</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2022.05.013</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>D</given-names></name><name><surname>Binan</surname><given-names>L</given-names></name><name><surname>Bezney</surname><given-names>J</given-names></name><name><surname>Simonton</surname><given-names>B</given-names></name><name><surname>Freedman</surname><given-names>J</given-names></name><name><surname>Frangieh</surname><given-names>CJ</given-names></name><name><surname>Dey</surname><given-names>K</given-names></name><name><surname>Geiger-Schuller</surname><given-names>K</given-names></name><name><surname>Eraslan</surname><given-names>B</given-names></name><name><surname>Gusev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Scalable genetic screening for regulatory circuits using compressed Perturb-seq</article-title><source>Nat Biotechnol</source><year>2023</year><pub-id pub-id-type="pmcid">PMC11035494</pub-id><pub-id pub-id-type="pmid">37872410</pub-id><pub-id pub-id-type="doi">10.1038/s41587-023-01964-9</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemi</surname><given-names>MEK</given-names></name><name><surname>Martin</surname><given-names>HC</given-names></name><name><surname>Rice</surname><given-names>DL</given-names></name><name><surname>Gallone</surname><given-names>G</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Kelemen</surname><given-names>M</given-names></name><name><surname>McAloney</surname><given-names>K</given-names></name><name><surname>McRae</surname><given-names>J</given-names></name><name><surname>Radford</surname><given-names>EJ</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Common genetic variants contribute to risk of rare severe neurodevelopmental disorders</article-title><source>Nature</source><year>2018</year><volume>562</volume><fpage>268</fpage><lpage>271</lpage><pub-id pub-id-type="pmcid">PMC6726472</pub-id><pub-id pub-id-type="pmid">30258228</pub-id><pub-id pub-id-type="doi">10.1038/s41586-018-0566-4</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirauta</surname><given-names>BA</given-names></name><name><surname>Seaton</surname><given-names>DD</given-names></name><name><surname>Bensaddek</surname><given-names>D</given-names></name><name><surname>Brenes</surname><given-names>A</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Kilpinen</surname><given-names>H</given-names></name><collab>HipSci Consortium</collab><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Lamond</surname><given-names>AI</given-names></name></person-group><article-title>Population-scale proteome variation in human induced pluripotent stem cells</article-title><source>Elife</source><year>2020</year><volume>9</volume><pub-id pub-id-type="pmcid">PMC7447446</pub-id><pub-id pub-id-type="pmid">32773033</pub-id><pub-id pub-id-type="doi">10.7554/eLife.57390</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JA</given-names></name><name><surname>Caragine</surname><given-names>C</given-names></name><name><surname>Daniloski</surname><given-names>Z</given-names></name><name><surname>Domingo</surname><given-names>J</given-names></name><name><surname>Barry</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Davis</surname><given-names>K</given-names></name><name><surname>Ziosi</surname><given-names>M</given-names></name><name><surname>Glinos</surname><given-names>DA</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens</article-title><source>Science</source><year>2023</year><volume>380</volume><elocation-id>eadh7699</elocation-id><pub-id pub-id-type="pmcid">PMC10518238</pub-id><pub-id pub-id-type="pmid">37141313</pub-id><pub-id pub-id-type="doi">10.1126/science.adh7699</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>R</given-names></name><name><surname>Gachechiladze</surname><given-names>MA</given-names></name><name><surname>Ludwig</surname><given-names>CH</given-names></name><name><surname>Laurie</surname><given-names>MT</given-names></name><name><surname>Hong</surname><given-names>JY</given-names></name><name><surname>Nathaniel</surname><given-names>D</given-names></name><name><surname>Prabhu</surname><given-names>AV</given-names></name><name><surname>Fernandopulle</surname><given-names>MS</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Abshari</surname><given-names>M</given-names></name><etal/></person-group><article-title>CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons</article-title><source>Neuron</source><year>2019</year><volume>104</volume><fpage>239</fpage><lpage>255</lpage><elocation-id>e12</elocation-id><pub-id pub-id-type="pmcid">PMC6813890</pub-id><pub-id pub-id-type="pmid">31422865</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2019.07.014</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasperini</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>AJ</given-names></name><name><surname>McFaline-Figueroa</surname><given-names>JL</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>MD</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Leith</surname><given-names>A</given-names></name><name><surname>Schreiber</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name><etal/></person-group><article-title>A Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens</article-title><source>Cell</source><year>2019</year><volume>176</volume><elocation-id>1516</elocation-id><pub-id pub-id-type="pmcid">PMC6690346</pub-id><pub-id pub-id-type="pmid">30612741</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.11.029</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>RM</given-names></name><name><surname>Bryan</surname><given-names>JG</given-names></name><name><surname>McFarland</surname><given-names>JM</given-names></name><name><surname>Weir</surname><given-names>BA</given-names></name><name><surname>Sizemore</surname><given-names>AE</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Dharia</surname><given-names>NV</given-names></name><name><surname>Montgomery</surname><given-names>PG</given-names></name><name><surname>Cowley</surname><given-names>GS</given-names></name><name><surname>Pantel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells</article-title><source>Nat Genet</source><year>2017</year><volume>49</volume><fpage>1779</fpage><lpage>1784</lpage><pub-id pub-id-type="pmcid">PMC5709193</pub-id><pub-id pub-id-type="pmid">29083409</pub-id><pub-id pub-id-type="doi">10.1038/ng.3984</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanson</surname><given-names>KR</given-names></name><name><surname>Hanna</surname><given-names>RE</given-names></name><name><surname>Hegde</surname><given-names>M</given-names></name><name><surname>Donovan</surname><given-names>KF</given-names></name><name><surname>Strand</surname><given-names>C</given-names></name><name><surname>Sullender</surname><given-names>ME</given-names></name><name><surname>Vaimberg</surname><given-names>EW</given-names></name><name><surname>Goodale</surname><given-names>A</given-names></name><name><surname>Root</surname><given-names>DE</given-names></name><name><surname>Piccioni</surname><given-names>F</given-names></name><etal/></person-group><article-title>Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><elocation-id>5416</elocation-id><pub-id pub-id-type="pmcid">PMC6303322</pub-id><pub-id pub-id-type="pmid">30575746</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-07901-8</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>CH</given-names></name><name><surname>Szalai</surname><given-names>B</given-names></name><name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name></person-group><article-title>Transfer of regulatory knowledge from human to mouse for functional genomics analysis</article-title><source>Biochim Biophys Acta Gene Regul Mech</source><year>2020</year><volume>1863</volume><elocation-id>194431</elocation-id><pub-id pub-id-type="pmid">31525460</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Dumitru</surname><given-names>R</given-names></name><name><surname>Lackford</surname><given-names>BL</given-names></name><name><surname>Freudenberg</surname><given-names>JM</given-names></name><name><surname>Singh</surname><given-names>AP</given-names></name><name><surname>Archer</surname><given-names>TK</given-names></name><name><surname>Jothi</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name></person-group><article-title>Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation</article-title><source>Stem Cells</source><year>2012</year><volume>30</volume><fpage>910</fpage><lpage>922</lpage><pub-id pub-id-type="pmcid">PMC3787717</pub-id><pub-id pub-id-type="pmid">22367759</pub-id><pub-id pub-id-type="doi">10.1002/stem.1070</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>J-S</given-names></name></person-group><article-title>Role of the Paf1 complex in the maintenance of stem cell pluripotency and development</article-title><source>FEBS J</source><year>2023</year><volume>290</volume><fpage>951</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">35869661</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Replogle</surname><given-names>JM</given-names></name><name><surname>Norman</surname><given-names>TM</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name><name><surname>Hussmann</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cogan</surname><given-names>JZ</given-names></name><name><surname>Meer</surname><given-names>EJ</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Riordan</surname><given-names>DP</given-names></name><name><surname>Srinivas</surname><given-names>N</given-names></name><etal/></person-group><article-title>Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing</article-title><source>Nat Biotechnol</source><year>2020</year><volume>38</volume><fpage>954</fpage><lpage>961</lpage><pub-id pub-id-type="pmcid">PMC7416462</pub-id><pub-id pub-id-type="pmid">32231336</pub-id><pub-id pub-id-type="doi">10.1038/s41587-020-0470-y</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Dolinski</surname><given-names>K</given-names></name><name><surname>Dwight</surname><given-names>SS</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Gene ontology: tool for the unification of biology The Gene Ontology Consortium</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmcid">PMC3037419</pub-id><pub-id pub-id-type="pmid">10802651</pub-id><pub-id pub-id-type="doi">10.1038/75556</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siepel</surname><given-names>A</given-names></name><name><surname>Bejerano</surname><given-names>G</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Hou</surname><given-names>M</given-names></name><name><surname>Rosenbloom</surname><given-names>K</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Spieth</surname><given-names>J</given-names></name><name><surname>Hillier</surname><given-names>LW</given-names></name><name><surname>Richards</surname><given-names>S</given-names></name><etal/></person-group><article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title><source>Genome Res</source><year>2005</year><volume>15</volume><fpage>1034</fpage><lpage>1050</lpage><pub-id pub-id-type="pmcid">PMC1182216</pub-id><pub-id pub-id-type="pmid">16024819</pub-id><pub-id pub-id-type="doi">10.1101/gr.3715005</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergmiller</surname><given-names>T</given-names></name><name><surname>Ackermann</surname><given-names>M</given-names></name><name><surname>Silander</surname><given-names>OK</given-names></name></person-group><article-title>Patterns of evolutionary conservation of essential genes correlate with their compensability</article-title><source>PLoS Genet</source><year>2012</year><volume>8</volume><elocation-id>e1002803</elocation-id><pub-id pub-id-type="pmcid">PMC3386227</pub-id><pub-id pub-id-type="pmid">22761596</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002803</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberzon</surname><given-names>A</given-names></name><name><surname>Birger</surname><given-names>C</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Ghandi</surname><given-names>M</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name></person-group><article-title>The Molecular Signatures Database (MSigDB) hallmark gene set collection</article-title><source>Cell Syst</source><year>2015</year><volume>1</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="pmcid">PMC4707969</pub-id><pub-id pub-id-type="pmid">26771021</pub-id><pub-id pub-id-type="doi">10.1016/j.cels.2015.12.004</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><article-title>Evolutionary conservation analysis between the essential and nonessential genes in bacterial genomes</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><elocation-id>13210</elocation-id><pub-id pub-id-type="pmcid">PMC4536490</pub-id><pub-id pub-id-type="pmid">26272053</pub-id><pub-id pub-id-type="doi">10.1038/srep13210</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wainberg</surname><given-names>M</given-names></name><name><surname>Kamber</surname><given-names>RA</given-names></name><name><surname>Balsubramani</surname><given-names>A</given-names></name><name><surname>Meyers</surname><given-names>RM</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><name><surname>Hornburg</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Jian</surname><given-names>R</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name><etal/></person-group><article-title>A genome-wide atlas of co-essential modules assigns function to uncharacterized genes</article-title><source>Nat Genet</source><year>2021</year><volume>53</volume><fpage>638</fpage><lpage>649</lpage><pub-id pub-id-type="pmcid">PMC8763319</pub-id><pub-id pub-id-type="pmid">33859415</pub-id><pub-id pub-id-type="doi">10.1038/s41588-021-00840-z</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costanzo</surname><given-names>M</given-names></name><name><surname>VanderSluis</surname><given-names>B</given-names></name><name><surname>Koch</surname><given-names>EN</given-names></name><name><surname>Baryshnikova</surname><given-names>A</given-names></name><name><surname>Pons</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Usaj</surname><given-names>M</given-names></name><name><surname>Hanchard</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name><etal/></person-group><article-title>A global genetic interaction network maps a wiring diagram of cellular function</article-title><source>Science</source><year>2016</year><volume>353</volume><pub-id pub-id-type="pmcid">PMC5661885</pub-id><pub-id pub-id-type="pmid">27708008</pub-id><pub-id pub-id-type="doi">10.1126/science.aaf1420</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>SQ</given-names></name><name><surname>Joung</surname><given-names>JK</given-names></name></person-group><article-title>Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases</article-title><source>Nat Rev Genet</source><year>2016</year><volume>17</volume><fpage>300</fpage><lpage>312</lpage><pub-id pub-id-type="pmcid">PMC7225572</pub-id><pub-id pub-id-type="pmid">27087594</pub-id><pub-id pub-id-type="doi">10.1038/nrg.2016.28</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doench</surname><given-names>JG</given-names></name></person-group><article-title>Am I ready for CRISPR? A user’s guide to genetic screens</article-title><source>Nat Rev Genet</source><year>2018</year><volume>19</volume><fpage>67</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">29199283</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zukeran</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Takaoka</surname><given-names>S</given-names></name><name><surname>Mohamed</surname><given-names>HMA</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Ikematsu</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name></person-group><article-title>The CCR4-NOT deadenylase activity contributes to generation of induced pluripotent stem cells</article-title><source>Biochem Biophys Res Commun</source><year>2016</year><volume>474</volume><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">27037025</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazzio</surname><given-names>TG</given-names></name><name><surname>Huff</surname><given-names>JT</given-names></name><name><surname>Panning</surname><given-names>B</given-names></name></person-group><article-title>Chromatin regulation Tip(60)s the balance in embryonic stem cell self-renewal</article-title><source>Cell Cycle</source><year>2008</year><volume>7</volume><fpage>3302</fpage><lpage>3306</lpage><pub-id pub-id-type="pmcid">PMC4476248</pub-id><pub-id pub-id-type="pmid">18948739</pub-id><pub-id pub-id-type="doi">10.4161/cc.7.21.6928</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>T-Q</given-names></name><name><surname>Fang</surname><given-names>K</given-names></name><name><surname>Zeng</surname><given-names>Z-C</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Y-Q</given-names></name></person-group><article-title>N6-methyladenosine methyltransferases: functions, regulation, and clinical potential</article-title><source>J Hematol Oncol</source><year>2021</year><volume>14</volume><fpage>117</fpage><pub-id pub-id-type="pmcid">PMC8313886</pub-id><pub-id pub-id-type="pmid">34315512</pub-id><pub-id pub-id-type="doi">10.1186/s13045-021-01129-8</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poli</surname><given-names>J</given-names></name><name><surname>Gasser</surname><given-names>SM</given-names></name><name><surname>Papamichos-Chronakis</surname><given-names>M</given-names></name></person-group><article-title>The INO80 remodeller in transcription, replication and repair</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2017</year><volume>372</volume><pub-id pub-id-type="pmcid">PMC5577468</pub-id><pub-id pub-id-type="pmid">28847827</pub-id><pub-id pub-id-type="doi">10.1098/rstb.2016.0290</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><collab>UniProt Consortium</collab><article-title>UniProt: a hub for protein information</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>D204</fpage><lpage>D212</lpage><pub-id pub-id-type="pmcid">PMC4384041</pub-id><pub-id pub-id-type="pmid">25348405</pub-id><pub-id pub-id-type="doi">10.1093/nar/gku989</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="pmcid">PMC8371605</pub-id><pub-id pub-id-type="pmid">34265844</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusaro</surname><given-names>G</given-names></name><name><surname>Dasgupta</surname><given-names>P</given-names></name><name><surname>Rastogi</surname><given-names>S</given-names></name><name><surname>Joshi</surname><given-names>B</given-names></name><name><surname>Chellappan</surname><given-names>S</given-names></name></person-group><article-title>Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>47853</fpage><lpage>47861</lpage><pub-id pub-id-type="pmid">14500729</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Wallner</surname><given-names>B</given-names></name></person-group><article-title>DockQ: A Quality Measure for Protein-Protein Docking Models</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><elocation-id>e0161879</elocation-id><pub-id pub-id-type="pmcid">PMC4999177</pub-id><pub-id pub-id-type="pmid">27560519</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0161879</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsitsiridis</surname><given-names>G</given-names></name><name><surname>Steinkamp</surname><given-names>R</given-names></name><name><surname>Giurgiu</surname><given-names>M</given-names></name><name><surname>Brauner</surname><given-names>B</given-names></name><name><surname>Fobo</surname><given-names>G</given-names></name><name><surname>Frishman</surname><given-names>G</given-names></name><name><surname>Montrone</surname><given-names>C</given-names></name><name><surname>Ruepp</surname><given-names>A</given-names></name></person-group><article-title>CORUM: the comprehensive resource of mammalian protein complexes-2022</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>D539</fpage><lpage>D545</lpage><pub-id pub-id-type="pmcid">PMC9825459</pub-id><pub-id pub-id-type="pmid">36382402</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkac1015</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagey</surname><given-names>MH</given-names></name><name><surname>Newman</surname><given-names>JJ</given-names></name><name><surname>Bilodeau</surname><given-names>S</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Orlando</surname><given-names>DA</given-names></name><name><surname>van Berkum</surname><given-names>NL</given-names></name><name><surname>Ebmeier</surname><given-names>CC</given-names></name><name><surname>Goossens</surname><given-names>J</given-names></name><name><surname>Rahl</surname><given-names>PB</given-names></name><name><surname>Levine</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Mediator and cohesin connect gene expression and chromatin architecture</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type="pmcid">PMC2953795</pub-id><pub-id pub-id-type="pmid">20720539</pub-id><pub-id pub-id-type="doi">10.1038/nature09380</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramasamy</surname><given-names>S</given-names></name><name><surname>Aljahani</surname><given-names>A</given-names></name><name><surname>Karpinska</surname><given-names>MA</given-names></name><name><surname>Cao</surname><given-names>TBN</given-names></name><name><surname>Velychko</surname><given-names>T</given-names></name><name><surname>Cruz</surname><given-names>JN</given-names></name><name><surname>Lidschreiber</surname><given-names>M</given-names></name><name><surname>Oudelaar</surname><given-names>AM</given-names></name></person-group><article-title>The Mediator complex regulates enhancer-promoter interactions</article-title><source>Nat Struct Mol Biol</source><year>2023</year><volume>30</volume><fpage>991</fpage><lpage>1000</lpage><pub-id pub-id-type="pmcid">PMC10352134</pub-id><pub-id pub-id-type="pmid">37430065</pub-id><pub-id pub-id-type="doi">10.1038/s41594-023-01027-2</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>K</given-names></name><name><surname>Jian</surname><given-names>D</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name></person-group><article-title>DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response</article-title><source>Oncol Rep</source><year>2021</year><volume>45</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="pmcid">PMC7859996</pub-id><pub-id pub-id-type="pmid">33650667</pub-id><pub-id pub-id-type="doi">10.3892/or.2021.7951</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AZ</given-names></name></person-group><article-title>DDX41: a multifunctional DEAD-box protein involved in pre-mRNA splicing and innate immunity</article-title><source>Biol Chem</source><year>2021</year><volume>402</volume><fpage>645</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">33711218</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinriki</surname><given-names>S</given-names></name><name><surname>Hirayama</surname><given-names>M</given-names></name><name><surname>Nagamachi</surname><given-names>A</given-names></name><name><surname>Yokoyama</surname><given-names>A</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Kanai</surname><given-names>A</given-names></name><name><surname>Kawai</surname><given-names>H</given-names></name><name><surname>Iwakiri</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Maeshiro</surname><given-names>M</given-names></name><etal/></person-group><article-title>DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells</article-title><source>Leukemia</source><year>2022</year><volume>36</volume><fpage>2605</fpage><lpage>2620</lpage><pub-id pub-id-type="pmcid">PMC9613458</pub-id><pub-id pub-id-type="pmid">36229594</pub-id><pub-id pub-id-type="doi">10.1038/s41375-022-01708-9</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dybkov</surname><given-names>O</given-names></name><name><surname>Preußner</surname><given-names>M</given-names></name><name><surname>El Ayoubi</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>V-Y</given-names></name><name><surname>Harnisch</surname><given-names>C</given-names></name><name><surname>Merz</surname><given-names>K</given-names></name><name><surname>Leupold</surname><given-names>P</given-names></name><name><surname>Yudichev</surname><given-names>P</given-names></name><name><surname>Agafonov</surname><given-names>DE</given-names></name><name><surname>Will</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Regulation of 3’ splice site selection after step 1 of splicing by spliceosomal C* proteins</article-title><source>Sci Adv</source><year>2023</year><volume>9</volume><elocation-id>eadf1785</elocation-id><pub-id pub-id-type="pmcid">PMC9984181</pub-id><pub-id pub-id-type="pmid">36867703</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.adf1785</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Ko</surname><given-names>J</given-names></name><name><surname>Ju</surname><given-names>C</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><article-title>Hypoxia signaling in human diseases and therapeutic targets</article-title><source>Exp Mol Med</source><year>2019</year><volume>51</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC6586801</pub-id><pub-id pub-id-type="pmid">31221962</pub-id><pub-id pub-id-type="doi">10.1038/s12276-019-0235-1</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>VH</given-names></name></person-group><article-title>The VHL tumor suppressor: master regulator of HIF</article-title><source>Curr Pharm Des</source><year>2009</year><volume>15</volume><fpage>3895</fpage><lpage>3903</lpage><pub-id pub-id-type="pmcid">PMC3622710</pub-id><pub-id pub-id-type="pmid">19671042</pub-id><pub-id pub-id-type="doi">10.2174/138161209789649394</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullen</surname><given-names>PJ</given-names></name><name><surname>Yu</surname><given-names>R</given-names></name><name><surname>Longo</surname><given-names>J</given-names></name><name><surname>Archer</surname><given-names>MC</given-names></name><name><surname>Penn</surname><given-names>LZ</given-names></name></person-group><article-title>The interplay between cell signalling and the mevalonate pathway in cancer</article-title><source>Nat Rev Cancer</source><year>2016</year><volume>16</volume><fpage>718</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">27562463</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuomo</surname><given-names>ASE</given-names></name><name><surname>Seaton</surname><given-names>DD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Martinez</surname><given-names>I</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Garcia-Bernardo</surname><given-names>J</given-names></name><name><surname>Amatya</surname><given-names>S</given-names></name><name><surname>Madrigal</surname><given-names>P</given-names></name><name><surname>Isaacson</surname><given-names>A</given-names></name><name><surname>Buettner</surname><given-names>F</given-names></name><etal/></person-group><article-title>Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>810</fpage><pub-id pub-id-type="pmcid">PMC7010688</pub-id><pub-id pub-id-type="pmid">32041960</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-14457-z</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>G</given-names></name><name><surname>Kyriakis</surname><given-names>D</given-names></name><name><surname>Grzyb</surname><given-names>K</given-names></name><name><surname>Bernini</surname><given-names>M</given-names></name><name><surname>Rodius</surname><given-names>S</given-names></name><name><surname>Dittmar</surname><given-names>G</given-names></name><name><surname>Finkbeiner</surname><given-names>S</given-names></name><name><surname>Skupin</surname><given-names>A</given-names></name></person-group><article-title>Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease</article-title><source>Commun Biol</source><year>2022</year><volume>5</volume><fpage>49</fpage><pub-id pub-id-type="pmcid">PMC8758783</pub-id><pub-id pub-id-type="pmid">35027645</pub-id><pub-id pub-id-type="doi">10.1038/s42003-021-02973-7</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakiba</surname><given-names>N</given-names></name><name><surname>White</surname><given-names>CA</given-names></name><name><surname>Lipsitz</surname><given-names>YY</given-names></name><name><surname>Yachie-Kinoshita</surname><given-names>A</given-names></name><name><surname>Tonge</surname><given-names>PD</given-names></name><name><surname>Hussein</surname><given-names>SMI</given-names></name><name><surname>Puri</surname><given-names>MC</given-names></name><name><surname>Elbaz</surname><given-names>J</given-names></name><name><surname>Morrissey-Scoot</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>CD24 tracks divergent pluripotent states in mouse and human cells</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><elocation-id>7329</elocation-id><pub-id pub-id-type="pmcid">PMC4490408</pub-id><pub-id pub-id-type="pmid">26076835</pub-id><pub-id pub-id-type="doi">10.1038/ncomms8329</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Lyu</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>M</given-names></name><name><surname>Jiapaer</surname><given-names>Z</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>T</given-names></name><name><surname>Weng</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The miR-590/Acvr2a/Terf1 Axis Regulates Telomere Elongation and Pluripotency of Mouse iPSCs</article-title><source>Stem Cell Reports</source><year>2018</year><volume>11</volume><fpage>88</fpage><lpage>101</lpage><pub-id pub-id-type="pmcid">PMC6066996</pub-id><pub-id pub-id-type="pmid">29910124</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.05.008</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hough</surname><given-names>SR</given-names></name><name><surname>Laslett</surname><given-names>AL</given-names></name><name><surname>Grimmond</surname><given-names>SB</given-names></name><name><surname>Kolle</surname><given-names>G</given-names></name><name><surname>Pera</surname><given-names>MF</given-names></name></person-group><article-title>A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><elocation-id>e7708</elocation-id><pub-id pub-id-type="pmcid">PMC2768791</pub-id><pub-id pub-id-type="pmid">19890402</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007708</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emani</surname><given-names>MR</given-names></name><name><surname>Närvä</surname><given-names>E</given-names></name><name><surname>Stubb</surname><given-names>A</given-names></name><name><surname>Chakroborty</surname><given-names>D</given-names></name><name><surname>Viitala</surname><given-names>M</given-names></name><name><surname>Rokka</surname><given-names>A</given-names></name><name><surname>Rahkonen</surname><given-names>N</given-names></name><name><surname>Moulder</surname><given-names>R</given-names></name><name><surname>Denessiouk</surname><given-names>K</given-names></name><name><surname>Trokovic</surname><given-names>R</given-names></name><etal/></person-group><article-title>The L1TD1 protein interactome reveals the importance of post-transcriptional regulation in human pluripotency</article-title><source>Stem Cell Reports</source><year>2015</year><volume>4</volume><fpage>519</fpage><lpage>528</lpage><pub-id pub-id-type="pmcid">PMC4376047</pub-id><pub-id pub-id-type="pmid">25702638</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.01.014</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwabuchi</surname><given-names>KA</given-names></name><name><surname>Yamakawa</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Ichisaka</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Okita</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group><article-title>ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSC generation, but it is dispensable for the maintenance and induction of pluripotency</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><elocation-id>e20461</elocation-id><pub-id pub-id-type="pmcid">PMC3102727</pub-id><pub-id pub-id-type="pmid">21637830</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0020461</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongtrakoongate</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Andrews</surname><given-names>PW</given-names></name></person-group><article-title>DNMT3B inhibits the re-expression of genes associated with induced pluripotency</article-title><source>Exp Cell Res</source><year>2014</year><volume>321</volume><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">24333507</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group><article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>663</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">16904174</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Belmonte</surname><given-names>JCI</given-names></name></person-group><article-title>Ground rules of the pluripotency gene regulatory network</article-title><source>Nat Rev Genet</source><year>2017</year><volume>18</volume><fpage>180</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">28045100</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riordan</surname><given-names>JD</given-names></name><name><surname>Nadeau</surname><given-names>JH</given-names></name></person-group><article-title>From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health</article-title><source>Am J Hum Genet</source><year>2017</year><volume>101</volume><fpage>177</fpage><lpage>191</lpage><pub-id pub-id-type="pmcid">PMC5544383</pub-id><pub-id pub-id-type="pmid">28777930</pub-id><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.06.004</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doench</surname><given-names>JG</given-names></name><name><surname>Fusi</surname><given-names>N</given-names></name><name><surname>Sullender</surname><given-names>M</given-names></name><name><surname>Hegde</surname><given-names>M</given-names></name><name><surname>Vaimberg</surname><given-names>EW</given-names></name><name><surname>Donovan</surname><given-names>KF</given-names></name><name><surname>Smith</surname><given-names>I</given-names></name><name><surname>Tothova</surname><given-names>Z</given-names></name><name><surname>Wilen</surname><given-names>C</given-names></name><name><surname>Orchard</surname><given-names>R</given-names></name><etal/></person-group><article-title>Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9</article-title><source>Nat Biotechnol</source><year>2016</year><volume>34</volume><fpage>184</fpage><lpage>191</lpage><pub-id pub-id-type="pmcid">PMC4744125</pub-id><pub-id pub-id-type="pmid">26780180</pub-id><pub-id pub-id-type="doi">10.1038/nbt.3437</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohatgi</surname><given-names>N</given-names></name><name><surname>Fortin</surname><given-names>JP</given-names></name><name><surname>Lau</surname><given-names>T</given-names></name><name><surname>Ying</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name><name><surname>Reja</surname><given-names>R</given-names></name></person-group><article-title>Seed sequences mediate off-target activity in the CRISPR-interference (CRISPRi) system</article-title><source>bioRxiv</source><year>2024</year><elocation-id>2024.04.10.588881</elocation-id><pub-id pub-id-type="pmcid">PMC11605690</pub-id><pub-id pub-id-type="pmid">39510079</pub-id><pub-id pub-id-type="doi">10.1016/j.xgen.2024.100693</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parts</surname><given-names>L</given-names></name><name><surname>Batté</surname><given-names>A</given-names></name><name><surname>Lopes</surname><given-names>M</given-names></name><name><surname>Yuen</surname><given-names>MW</given-names></name><name><surname>Laver</surname><given-names>M</given-names></name><name><surname>Luis</surname><given-names>BS</given-names></name><name><surname>Yue</surname><given-names>J</given-names></name><name><surname>Pons</surname><given-names>C</given-names></name><name><surname>Eray</surname><given-names>E</given-names></name><name><surname>Aloy</surname><given-names>P</given-names></name><etal/></person-group><article-title>Natural variants suppress mutations in hundreds of essential genes</article-title><source>Mol Syst Biol</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8156963</pub-id><pub-id pub-id-type="pmid">34042294</pub-id><pub-id pub-id-type="doi">10.15252/msb.202010138</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ünlü</surname><given-names>B</given-names></name><name><surname>Pons</surname><given-names>C</given-names></name><name><surname>Ho</surname><given-names>UL</given-names></name><name><surname>Batté</surname><given-names>A</given-names></name><name><surname>Aloy</surname><given-names>P</given-names></name><name><surname>van Leeuwen</surname><given-names>J</given-names></name></person-group><article-title>Global analysis of suppressor mutations that rescue human genetic defects</article-title><source>Genome Med</source><year>2023</year><volume>15</volume><pub-id pub-id-type="pmcid">PMC10568808</pub-id><pub-id pub-id-type="pmid">37821946</pub-id><pub-id pub-id-type="doi">10.1186/s13073-023-01232-0</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usluer</surname><given-names>S</given-names></name><name><surname>Hallast</surname><given-names>P</given-names></name><name><surname>Crepaldi</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Urgo</surname><given-names>K</given-names></name><name><surname>Dincer</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Noell</surname><given-names>G</given-names></name><name><surname>Alasoo</surname><given-names>K</given-names></name><name><surname>El Garwany</surname><given-names>O</given-names></name><etal/></person-group><article-title>Optimized whole-genome CRISPR interference screens identify ARID1A-dependent growth regulators in human induced pluripotent stem cells</article-title><source>Stem Cell Reports</source><year>2023</year><volume>18</volume><fpage>1061</fpage><lpage>1074</lpage><pub-id pub-id-type="pmcid">PMC10202655</pub-id><pub-id pub-id-type="pmid">37028423</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2023.03.008</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nat Biotechnol</source><year>2018</year><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="pmcid">PMC6700744</pub-id><pub-id pub-id-type="pmid">29608179</pub-id><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzelepis</surname><given-names>K</given-names></name><name><surname>Koike-Yusa</surname><given-names>H</given-names></name><name><surname>De Braekeleer</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Metzakopian</surname><given-names>E</given-names></name><name><surname>Dovey</surname><given-names>OM</given-names></name><name><surname>Mupo</surname><given-names>A</given-names></name><name><surname>Grinkevich</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Mazan</surname><given-names>M</given-names></name><etal/></person-group><article-title>A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia</article-title><source>Cell Rep</source><year>2016</year><volume>17</volume><fpage>1193</fpage><lpage>1205</lpage><pub-id pub-id-type="pmcid">PMC5081405</pub-id><pub-id pub-id-type="pmid">27760321</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.079</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusa</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>MA</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>Craig</surname><given-names>NL</given-names></name></person-group><article-title>A hyperactive piggyBac transposase for mammalian applications</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>1531</fpage><lpage>1536</lpage><pub-id pub-id-type="pmcid">PMC3029773</pub-id><pub-id pub-id-type="pmid">21205896</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1008322108</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripley</surname><given-names>BD</given-names></name></person-group><article-title>The R project in statistical computing</article-title><source>MSOR Connect</source><year>2001</year><volume>1</volume><fpage>23</fpage><lpage>25</lpage></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Belgrader</surname><given-names>P</given-names></name><name><surname>Ryvkin</surname><given-names>P</given-names></name><name><surname>Bent</surname><given-names>ZW</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Ziraldo</surname><given-names>SB</given-names></name><name><surname>Wheeler</surname><given-names>TD</given-names></name><name><surname>McDermott</surname><given-names>GP</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Massively parallel digital transcriptional profiling of single cells</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><elocation-id>14049</elocation-id><pub-id pub-id-type="pmcid">PMC5241818</pub-id><pub-id pub-id-type="pmid">28091601</pub-id><pub-id pub-id-type="doi">10.1038/ncomms14049</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><article-title>Cellsnp-lite: an efficient tool for genotyping single cells</article-title><source>Bioinformatics</source><year>2021</year><pub-id pub-id-type="pmid">33963851</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Liddle</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Pollard</surname><given-names>MO</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><name><surname>Keane</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Twelve years of SAMtools and BCFtools</article-title><source>Gigascience</source><year>2021</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC7931819</pub-id><pub-id pub-id-type="pmid">33590861</pub-id><pub-id pub-id-type="doi">10.1093/gigascience/giab008</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="web"><source>CellSNP - browse/SNPlist at SourceForge.Net</source><comment><ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/cellsnp/files/SNPlist/">https://sourceforge.net/projects/cellsnp/files/SNPlist/</ext-link></comment></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name></person-group><article-title>Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference</article-title><source>Genome Biol</source><year>2019</year><volume>20</volume><fpage>273</fpage><pub-id pub-id-type="pmcid">PMC6909514</pub-id><pub-id pub-id-type="pmid">31836005</pub-id><pub-id pub-id-type="doi">10.1186/s13059-019-1865-2</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Kocher</surname><given-names>J-P</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>CrossMap: a versatile tool for coordinate conversion between genome assemblies</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>1006</fpage><lpage>1007</lpage><pub-id pub-id-type="pmcid">PMC3967108</pub-id><pub-id pub-id-type="pmid">24351709</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btt730</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luecken</surname><given-names>MD</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><article-title>Current best practices in single-cell RNA-seq analysis: a tutorial</article-title><source>Mol Syst Biol</source><year>2019</year><volume>15</volume><elocation-id>e8746</elocation-id><pub-id pub-id-type="pmcid">PMC6582955</pub-id><pub-id pub-id-type="pmid">31217225</pub-id><pub-id pub-id-type="doi">10.15252/msb.20188746</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunger</surname><given-names>JM</given-names></name><name><surname>Velten</surname><given-names>B</given-names></name></person-group><article-title>Guide assignment in single-cell CRISPR screens using crispat</article-title><source>bioRxiv</source><year>2024</year><elocation-id>2024.05.06.592692</elocation-id><pub-id pub-id-type="pmcid">PMC11399228</pub-id><pub-id pub-id-type="pmid">39240651</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btae535</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Mächler</surname><given-names>M</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Fitting Linear Mixed-Effects Models Using lme4</article-title><source>J Stat Softw</source><year>2015</year><volume>67</volume><fpage>1</fpage><lpage>48</lpage></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abugessaisa</surname><given-names>I</given-names></name><name><surname>Noguchi</surname><given-names>S</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Kasukawa</surname><given-names>T</given-names></name></person-group><article-title>The FANTOM5 Computation Ecosystem: Genomic Information Hub for Promoters and Active Enhancers</article-title><source>Methods Mol Biol</source><year>2017</year><volume>1611</volume><fpage>199</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">28451981</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgkins</surname><given-names>A</given-names></name><name><surname>Farne</surname><given-names>A</given-names></name><name><surname>Perera</surname><given-names>S</given-names></name><name><surname>Grego</surname><given-names>T</given-names></name><name><surname>Parry-Smith</surname><given-names>DJ</given-names></name><name><surname>Skarnes</surname><given-names>WC</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name></person-group><article-title>WGE: a CRISPR database for genome engineering</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>3078</fpage><lpage>3080</lpage><pub-id pub-id-type="pmcid">PMC4565030</pub-id><pub-id pub-id-type="pmid">25979474</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btv308</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Lab</surname><given-names>S-R</given-names></name></person-group><source>OmniPath :: Intra- &amp; intercellular signaling knowledge</source><comment><ext-link ext-link-type="uri" xlink:href="https://omnipathdb.org/">https://omnipathdb.org/</ext-link></comment></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Türei</surname><given-names>D</given-names></name><name><surname>Korcsmáros</surname><given-names>T</given-names></name><name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name></person-group><article-title>OmniPath: guidelines and gateway for literature-curated signaling pathway resources</article-title><source>Nat Methods</source><year>2016</year><pub-id pub-id-type="pmid">27898060</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Alonso</surname><given-names>L</given-names></name><name><surname>Holland</surname><given-names>CH</given-names></name><name><surname>Ibrahim</surname><given-names>MM</given-names></name><name><surname>Turei</surname><given-names>D</given-names></name><name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name></person-group><article-title>Benchmark and integration of resources for the estimation of human transcription factor activities</article-title><source>Genome Res</source><year>2019</year><volume>29</volume><fpage>1363</fpage><lpage>1375</lpage><pub-id pub-id-type="pmcid">PMC6673718</pub-id><pub-id pub-id-type="pmid">31340985</pub-id><pub-id pub-id-type="doi">10.1101/gr.240663.118</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badia-i-Mompel</surname><given-names>P</given-names></name><name><surname>Vélez Santiago</surname><given-names>J</given-names></name><name><surname>Braunger</surname><given-names>J</given-names></name><name><surname>Geiss</surname><given-names>C</given-names></name><name><surname>Dimitrov</surname><given-names>D</given-names></name><name><surname>Müller-Dott</surname><given-names>S</given-names></name><name><surname>Taus</surname><given-names>P</given-names></name><name><surname>Dugourd</surname><given-names>A</given-names></name><name><surname>Holland</surname><given-names>CH</given-names></name><name><surname>Ramirez Flores</surname><given-names>RO</given-names></name><etal/></person-group><article-title>decoupleR: ensemble of computational methods to infer biological activities from omics data</article-title><source>Bioinformatics Advances</source><year>2022</year><volume>2</volume><elocation-id>vbac016</elocation-id><pub-id pub-id-type="pmcid">PMC9710656</pub-id><pub-id pub-id-type="pmid">36699385</pub-id><pub-id pub-id-type="doi">10.1093/bioadv/vbac016</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Arak</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name></person-group><article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title><source>Nucleic Acids Res</source><year>2019</year><volume>47</volume><fpage>W191</fpage><lpage>W198</lpage><pub-id pub-id-type="pmcid">PMC6602461</pub-id><pub-id pub-id-type="pmid">31066453</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>J</given-names></name><name><surname>Hastie</surname><given-names>T</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name></person-group><article-title>Regularization Paths for Generalized Linear Models via Coordinate Descent</article-title><source>J Stat Softw</source><year>2010</year><volume>33</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="pmcid">PMC2929880</pub-id><pub-id pub-id-type="pmid">20808728</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>O’Neill</surname><given-names>M</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Antropova</surname><given-names>N</given-names></name><name><surname>Senior</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Blackwell</surname><given-names>S</given-names></name><name><surname>Yim</surname><given-names>J</given-names></name><etal/></person-group><article-title>Protein complex prediction with AlphaFold-Multimer</article-title><source>bioRxiv</source><year>2022</year><elocation-id>2021.10.04.463034</elocation-id><pub-id pub-id-type="doi">10.1101/2021.10.04.463034</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>P</given-names></name><name><surname>Pozzati</surname><given-names>G</given-names></name><name><surname>Elofsson</surname><given-names>A</given-names></name></person-group><article-title>Improved prediction of protein-protein interactions using AlphaFold2</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>1265</elocation-id><pub-id pub-id-type="pmcid">PMC8913741</pub-id><pub-id pub-id-type="pmid">35273146</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-28865-w</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="web"><collab>PyMOL</collab><comment><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/pymol">http://www.pymol.org/pymol</ext-link></comment></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argelaguet</surname><given-names>R</given-names></name><name><surname>Velten</surname><given-names>B</given-names></name><name><surname>Arnol</surname><given-names>D</given-names></name><name><surname>Dietrich</surname><given-names>S</given-names></name><name><surname>Zenz</surname><given-names>T</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Buettner</surname><given-names>F</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name></person-group><article-title>Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets</article-title><source>Mol Syst Biol</source><year>2018</year><volume>14</volume><elocation-id>e8124</elocation-id><pub-id pub-id-type="pmcid">PMC6010767</pub-id><pub-id pub-id-type="pmid">29925568</pub-id><pub-id pub-id-type="doi">10.15252/msb.20178124</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argelaguet</surname><given-names>R</given-names></name><name><surname>Arnol</surname><given-names>D</given-names></name><name><surname>Bredikhin</surname><given-names>D</given-names></name><name><surname>Deloro</surname><given-names>Y</given-names></name><name><surname>Velten</surname><given-names>B</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name></person-group><article-title>MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data</article-title><source>Genome Biol</source><year>2020</year><volume>21</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmcid">PMC7212577</pub-id><pub-id pub-id-type="pmid">32393329</pub-id><pub-id pub-id-type="doi">10.1186/s13059-020-02015-1</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokic</surname><given-names>G</given-names></name><name><surname>Wagner</surname><given-names>FR</given-names></name><name><surname>Chernev</surname><given-names>A</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name></person-group><article-title>Structural basis of human transcription–DNA repair coupling</article-title><source>Nature</source><year>2021</year><volume>598</volume><fpage>368</fpage><lpage>372</lpage><pub-id pub-id-type="pmcid">PMC8514338</pub-id><pub-id pub-id-type="pmid">34526721</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03906-4</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenner</surname><given-names>LR</given-names></name><name><surname>Anand</surname><given-names>AA</given-names></name><name><surname>Nguyen</surname><given-names>HC</given-names></name><name><surname>Myasnikov</surname><given-names>AG</given-names></name><name><surname>Klose</surname><given-names>CJ</given-names></name><name><surname>McGeever</surname><given-names>LA</given-names></name><name><surname>Tsai</surname><given-names>JC</given-names></name><name><surname>Miller-Vedam</surname><given-names>LE</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Frost</surname><given-names>A</given-names></name></person-group><article-title>eIF2B-catalyzed nucleotide exchange and phosphoregulation by the integrated stress response</article-title><source>Science</source><year>2019</year><volume>364</volume><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="pmcid">PMC6601628</pub-id><pub-id pub-id-type="pmid">31048491</pub-id><pub-id pub-id-type="doi">10.1126/science.aaw2922</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Quantifying knockdown effects in cells from multiple donors at scale.</title><p>A) Experimental design of a genome-scale CRISPRi screen with single-cell RNA-seq read-out from 34 human iPSC cell lines. B) UMAP of the expression profiles of cells assigned to a donor and targeting guide after correcting for technical covariates, colored by cell line. C) Variance decomposition, displaying relative effects of cell line, genomic background and target gene perturbation on gene expression. D) Overview of the analysis strategy to understand individual <italic>trans</italic> effects (orange), E) similarity of effects across all genes (green), F) and similarity of perturbation responses across all targets (purple).</p></caption><graphic xlink:href="EMS201574-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Global transcriptional changes caused by gene-dosage reduction.</title><p>A) Histogram of the number of significant trans effects per target. Target genes with the highest numbers are labelled. B) Model coefficients (x-axis) for predicting number of <italic>trans</italic> effects based on properties of the target gene (y-axis, DPI = days post infection). C) Heatmap of targets by <italic>trans</italic> effect similarity for the 280 knockdowns (with at least two co-regulating targets and at least one <italic>trans</italic> effect). D) Model coefficients (y-axis) for predicting similarity between <italic>trans</italic> effects based on functional relationship of two target genes (x-axis) E) Scatter plot of the <italic>trans</italic> effects induced by knockdown of genes in the TOMM40 complex (<italic>x</italic>-axis) and <italic>PHB (y</italic>-axis). F) Top view of an α-helix on <italic>PHB</italic> (green) predicted to interact with the β-barrel of the TOMM40 (blue) complex in a similar manner to known complex members, via a shared interface with <italic>TOMM7<sup><xref ref-type="bibr" rid="R37">37</xref></sup></italic> (yellow). G) Heatmap of correlation between expressed genes based on perturbation responses (lower-triangle) and natural single-cell co-expression (upper-triangle) for 313 expressed genes with the most co-regulated expressed genes (&gt; 3 co-regulated genes). H) The regulatory behavior of hypoxia regulators <italic>HIF1A</italic>, <italic>ARNT</italic> and <italic>VHL</italic> on the glycolysis pathway. I) Regulators of commonly used iPSC marker genes. Knockdowns are indicated by green nodes while downstream genes are indicated in purple. Down-regulation upon knockdown is indicated in blue while up-regulation is indicated by a red arrow.</p></caption><graphic xlink:href="EMS201574-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Genetic background influences perturbation response.</title><p>A) Analysis of variation in <italic>trans</italic> effects by considering a panel of 444 targets across 10 donors, with 2 cell lines per donor. B) Knockdowns with the most and least heritable <italic>trans</italic> effects, controlling for the number of <italic>trans</italic> effects tested. C) Breakdown of heritable, perturbation-induced, transcriptional change (out of 3,051). D) Mean transcriptional fold-change of <italic>trans</italic> effects resulting in loss of heritability of expression. E) Mean transcriptional fold-change of <italic>trans</italic> effects resulting in gain in heritability of expression. F) Expression change of <italic>MICU2</italic> due to knockdown of eQTL hotspot <italic>CREB3L2</italic>. G) Expression change of <italic>PRKD3</italic> due to knockdown of <italic>OCT4</italic>, separated by allele of a cis-eQTL of <italic>PRKD3</italic>.</p></caption><graphic xlink:href="EMS201574-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Robustness of knockdown effects to inter-individual differences.</title></caption><graphic xlink:href="EMS201574-f004"/></fig></floats-group></article>